§ 1. Formål
fastsette hva som er narkotika forebygge spredning og misbruk av narkotika, herunder sikre forsvarlige kontrolltiltak sikre tilgang til nødvendige legemidler til medisinsk og vitenskapelig bruk.
| Stoffnavn | Internasjonal regulering | Forbudt etter § 5 | Unntak og spesielle bestemmelser | CAS-nummer |
|---|---|---|---|---|
| 1-(3-Klorfenyl)-piperazin (mCPP) | Forbudt etter § 5 | 6640-24-0 | ||
| 1,4-Butandiol | 110-63-4 | |||
| 1-Benzylpiperazin (BZP) | P II | Forbudt etter § 5 | 2759-28-6 | |
| 1-Fenyl-2-(1-metyletylamino)pentan-1-on (N-isopropylpentedron) | Forbudt etter § 5 | 18296-65-6 | ||
| 2-(4-Metylpiperazin-1-yl)-1-fenylpropan-1-on | Forbudt etter § 5 | 93865-44-2 | ||
| 2-(Etylamino)-1-fenylheptan-1-on; se N-etyl heptedron | – | |||
| 2-(Etylamino)propiofenon (etkatinon) |
| 2-(4-Metylpiperazin-1-yl)-1-fenylpropan-1-on | 2-(4-metylpiperazin-1-yl)-1-fenyl-propan-1-on; 2-(4-metyl-1-piperazinyl)-1-fenyl-1-propanon; 2-(4-metylpiperazin-1-yl)-1-fenylpropan-1-on |
| 2,3-Dimetyletkatinon | 1-(2,3-dimetylfenyl)-2-(etylamino)propan-1-on |
| 2,3-DMMC | 2,3-dimetylmetkatinon |
| 2,3-MDMC | 1-(1,3-benzodioksol-4-yl)-2-(metylamino)propan-1-on |
| 2,4,5-TMMC | 2,4,5-trimetylmetkatinon |
| 2,4-DMMC | 2,4-dimetylmetkatinon |
| 2,4-DMPPP | 1-(2,4-dimetylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
| 2,5-Dimetoksy-4-etyltioamfetamin | 1-[4-(etylsulfanyl)-2,5-dimetoksyfenyl] propan-2-amin; 4-(etyltio)-2,5-dimetoksy-α-metyl-benzenetanamin |
| 2,5-Dimetoksy-4-isopropylamfetamin | 1-[2,5-dimetoksy-(propan-2-yl)fenyl]propan-2-amin; 1-(2,5-dimetoksy-4-propan-2-ylfenyl)propan-2-amin |
| 2,5-Dimetoksyamfetamin | 1-(2,5-dimetoksyfenyl)propan-2-amin; 1-(2,5-dimetoksyfenyl)-2-aminopropan |
| 2,5-DMMA | 2,5-dimetoksy-N,α-dimetyl-benzenetanamin; 1-(2,5-dimetoksyfenyl)-N-metylpropan-2-amin |
| 2,6-Dibrom-meskalin | 2-(2,6-dibrom-3,4,5-trimetoksyfenyl)etanamin; 2,6-dibrom-3,4,5-trimetoksy-fenetylamin |
| 25N-NBOMe | 2,5-dimetoksy-N-[(2-metoksyfenyl)metyl]-4-nitro-benzenetanamin; 2-(2,5-dimetoksy-4-nitrofenyl)-N-[(2-metoksyfenyl)metyl]etan-1-amin;2-(2,5-dimetoksy-4-nitrofenyl)-N-[(2-metoksyfenyl)metyl]etanamin |


| Forbudt etter § 5 |
| 18259-37-5 |
| 2-(Metylamino)-1-fenylheksan-1-on (heksedron) | Forbudt etter § 5 | 2169446-41-5 |
| 2,3-Dimetyletkatinon (2,3-DMEC) | Forbudt etter § 5 | 2705531-06-0 (HCl-salt) |
| 2,3-DMMC | Forbudt etter § 5 | 1448258-72-7 |
| 2,3-MDMC (2,3-metylendioksymetkatinon) | Forbudt etter § 5 | 1427205-87-5 |
| 2,4,5-TMMC | Forbudt etter § 5 | 1368603-85-3 |
| 2,4-DMMC | Forbudt etter § 5 | 1225623-63-1 |
| 2,4-DMPPP | Forbudt etter § 5 | – |
| 2,5-Dimetoksy-4-etyltioamfetamin (aleph-2) | Forbudt etter § 5 | 185562-00-9 |
| 2,5-Dimetoksy-4-fluoramfetamin | Forbudt etter § 5 | 125903-69-7 |
| 2,5-Dimetoksy-4-isopropylamfetamin (DOiP, DOiPr) | Forbudt etter § 5 | 42306-96-7 |
| 2,5-Dimetoksy-4-nitroamfetamin | Forbudt etter § 5 | 67460-68-8 |
| 2,5-Dimetoksyamfetamin (2,5-DMA) | Forbudt etter § 5 | 2801-68-5 |
| 2,5-DMMA (2,5-dimetoksymetamfetamin; metyl-DMA (2,5-dimetoksy-N-metylamfetamin)) | Forbudt etter § 5 | 54687-43-3 |
| 2,6-Dibrom-meskalin | Forbudt etter § 5 | 734477-60-2 |
| 25N-NBOMe (2C-N-NBOMe, NBOMe-2C-N) | Forbudt etter § 5 | 1354632-03-3 |
| 2-Brom-4,5-dimetoksyfenetylamin; se 4,5-dimetoksy-2-bromfenetylamin | 63375-81-5 |
| 2-Brom-meskalin (2-Br-M) | Forbudt etter § 5 | 37015-19-3 |
| 2C-B | P II | Forbudt etter § 5 | 66142-81-2 |
| 2C-B-FLY | Forbudt etter § 5 | 733720-95-1 |
| 2C-B-NBOMe (NBOMe-2-C-B, 25B-NBOMe) | P I | Forbudt etter § 5 | 1026511-90-9 |
| 2C-C | 88441-14-9 |
| 2C-C-NBOMe (NBOMe-2C-C, 25C-NBOMe) | P I | Forbudt etter § 5 | 1227608-02-7 |
| 2C-D | 24333-19-5 |
| 2C-D-NBOMe (NBOMe-2C-D, 25D-NBOMe) | 1354632-02-2 |
| 2C-E | 71539-34-9 |
| 2-CEC | Forbudt etter § 5 | 879660-23-8 (HCl-salt) |
| 2C-E-NBOMe (NBOMe-2C-E, 25E-NBOMe) | Forbudt etter § 5 | 1354632-14-6 |
| 2C-F | Forbudt etter § 5 | 207740-15-6 |
| 2C-G | Forbudt etter § 5 | 207740-18-9 |
| 2C-G-NB-OMe (NBOMe-2C-G, 25G-NBOMe) | Forbudt etter § 5 | 1354632-65-7 |
| 2C-H | Forbudt etter § 5 | 3600-86-0 |
| 2C-H-NBOMe (NBOMe-2C-H, 25H-NBOMe) | Forbudt etter § 5 | 919797-16-3 |
| 2C-I | 69587-11-7 |
| 2C-I-NBOMe (25I-NBOMe) | P I | Forbudt etter § 5 | 919797-19-6 |
| 2C-iP (jelena) | Forbudt etter § 5 | 1498978-47-4 |
| 2-Cl-4,5-MDMA | Forbudt etter § 5 | – |
| 2-CMC | Forbudt etter § 5 | 90869-66-2 (HCl-salt) |
| 2C-P | 207740-22-5 |
| 2C-T-2 | 207740-24-7 |
| 2C-T-21 (4-(2-fluoretyltio)-2,5-dimetoksyfenetylamin) | Forbudt etter § 5 | 207740-33-8 |
| 2C-T-4 | 207740-25-8 |
| 2C-T-7 | 207740-26-9 |
| 2-EEC | Forbudt etter § 5 | 1439439-82-3 |
| 2-EMC | Forbudt etter § 5 | 1863642-82-3 |
| 2-FA | Forbudt etter § 5 | 1716-60-5 |
| 2-FEA | Forbudt etter § 5 | 3871-89-4 (HCl-salt) |
| 2-Fluordesklorketamin | P II | Forbudt etter § 5 | 111982-50-4 |
| 2-Fluorfentanyl (ortofluorfentanyl) | N I | Forbudt etter § 5 | 910616-29-4 |
| 2-FMA | Forbudt etter § 5 | 1017176-48-5 |
| 2-FMC | Forbudt etter § 5 | 1346599-37-8 (HCl-salt) |
| 2-Klor-N-etylamfetamin | Forbudt etter § 5 | 1153916-07-4 |
| 2-MA (ortetamin) | Forbudt etter § 5 | 5580-32-5 |
| 2-MEC | Forbudt etter § 5 | 1439439-84-5 |
| 2-Me-PVP (2-metyl-α-PVP, 2'-Me-PVP) | Forbudt etter § 5 | 850352-54-4 |
| 2-Metylacetylfentanyl | Forbudt etter § 5 | – |
| 2-Metyl-AP-237 | N I | Forbudt etter § 5 | 98608-61-8 |
| 2-Metyletylbufedron (2-metyl-N-etylbufedron, 2-metyl-α-etylaminobutiofenon) | Forbudt etter § 5 | 690616-16-1 |
| 2-Metylmetamfetamin | Forbudt etter § 5 | 861007-65-0 |
| 2-Metylmetoksyacetylfentanyl (orto-metyl metoksyacetyl fentanyl) | Forbudt etter § 5 | 2748485-23-4 (HCl-salt) |
| 2-Metyl-α-PiHP (2-metyl-α-PHiP, 2-metyl-α-pyrrolidinoisoheksanofenon) | Forbudt etter § 5 | – |
| 2-MMA | Forbudt etter § 5 | 93-30-1 |
| 2-MMC | Forbudt etter § 5 | 1246911-71-6 |
| 3,4-DCEC | Forbudt etter § 5 | 2518105-51-4 (HCl-salt) |
| 3,4-Diklor-N,N-sykloheksylmetylkatinon | Forbudt etter § 5 | – |
| 3,4-Dimetoksy-α-PHP | Forbudt etter § 5 | – |
| 3,4-Dimetyletkatinon (3,4-DMEC) | Forbudt etter § 5 | 1225811-81-3 |
| 3,4-Dimetyl-α-PVP (3',4'-dimetyl-α-pyrrolidinovalerofenon) | Forbudt etter § 5 | 2748485-15-4 (HCl-salt) |
| 3,4-DMA | Forbudt etter § 5 | 120-26-3 |
| 3,4-DMMC | 1082110-00-6 |
| 3,4-EDMC (bk-EDMA) | Forbudt etter § 5 | 30253-44-2 (HCl-salt) |
| 3',4'-MDPBP (MDPBP) | Forbudt etter § 5 | 784985-33-7 |
| 3',4'-MDPHP (MDPHP) | Forbudt etter § 5 | 776994-64-0 |
| 3,4-Metylendioksy PV8, MDPEP (MD-PV8, MDPHPP) | Forbudt etter § 5 | 746541-09-3 |
| 3,4-Metylendioksy-α-pyrrolidinoisoheksanofenon (3,4-metylendioksy PiHP, MDPiHP) | Forbudt etter § 5 | 749145-17-3 |
| 3',4'-Tetrametylen-α-pyrrolidinobutiofenon (TH-PBP) | Forbudt etter § 5 | 2749504-65-0 (HCl-salt) |
| 3-Allylfentanyl | Forbudt etter § 5 | 86151-80-6 |
| 3-BMC | Forbudt etter § 5 | 676487-42-6 (HCl-salt) |
| 3-CEC | Forbudt etter § 5 | 2150476-60-9 |
| 3-CMC (klofedron) | P II | Forbudt etter § 5 | 1049677-59-9 |
| 3-Desoksy-MDPV; se 5-DBFPV | 2117405-32-8 |
| 3-EEC | Forbudt etter § 5 | – |
| 3-EMC | Forbudt etter § 5 | 1603134-08-2 |
| 3-FA | Forbudt etter § 5 | 1626-71-7 |
| 3-Fluoretylamfetamin (3-fluoretamfetamin, 3-FEA) | Forbudt etter § 5 | 54982-43-3 |
| 3-Fluorfentanyl | Forbudt etter § 5 | – |
| 3-Fluorisobutyrfentanyl (3-FIBF, meta-fluorisobutyrfentanyl) | Forbudt etter § 5 | – |
| 3-Fluormetoksyacetylfentanyl | Forbudt etter § 5 | – |
| 3-Fluor-α-PPP (3'-fluor-α-pyrrolidinopropiofenon) | Forbudt etter § 5 | 1214940-15-4 (HCl-salt) |
| 3-FMA | Forbudt etter § 5 | 1182818-14-9 |
| 3-FMC | Forbudt etter § 5 | 1049677-77-1 |
| 3F-NEB (3-fluor-N-etylbufedron, 3-fluor-α-etylaminobutiofenon) | Forbudt etter § 5 | – |
| 3F-NEH (3F-N-etylheksedron) | Forbudt etter § 5 | – |
| 3F-PHP (3-fluor-α-PHP, 3F-α-pyrrolidinoheksanofenon) | Forbudt etter § 5 | – |
| 3F-PiHP (3F-α-PHiP) | Forbudt etter § 5 | – |
| 3F-α-PVP | Forbudt etter § 5 | – |
| 3-Klorkatinon | Forbudt etter § 5 | 119802-69-6 |
| 3-Klor-N-etylamfetamin | Forbudt etter § 5 | 744983-82-2 |
| 3-MAM | 5140-28-3 |
| 3-MeA | Forbudt etter § 5 | 77083-25-1 |
| 3-MEC | Forbudt etter § 5 | 2493976-59-1 (HCl-salt) |
| 3-MeOMC | Forbudt etter § 5 | 882302-56-9 |
| 3-MeO-NBOMe (3-MeO-PEA-NBOMe) | Forbudt etter § 5 | 1176460-16-4 |
| 3'-Me-PVP (3'-Me-α-PVP, meta-pyrovaleron) | Forbudt etter § 5 | 13415-85-5 |
| 3-Metoksyamfetamin (3-MA; meta-metoksyamfetamin, MMA) | Forbudt etter § 5 | 17862-85-0 |
| 3-Metoksyfensyklidin (3-MeO-PCP) | P II | Forbudt etter § 5 | 72242-03-6 |
| 3-Metylbutyrfentanyl (3-MBF) | Forbudt etter § 5 | 97605-09-9 |
| 3-Metylfentanyl | N I+IV | Forbudt etter § 5 | 42045-86-3 |
| 3-Metylflefedron | Forbudt etter § 5 | – |
| 3-Metylkrotonylfentanyl | Forbudt etter § 5 | – |
| 3-Metyl-N-propyl-katinon (3-metyl-α -propylaminopropiofenon) | Forbudt etter § 5 | – |
| 3-Metyltiofentanyl | N I+IV | Forbudt etter § 5 | 86052-04-2 |
| 3-Metyl-α-PHiP (3-metyl-α-PiHP, 3-metyl-α-pyrrolidinoisoheksanofenon) | Forbudt etter § 5 | – |
| 3-MMC | P II | Forbudt etter § 5 | 1246816-62-5 |
| 4,4'-DMAR | P II | Forbudt etter § 5 | 1445569-01-6 |
| 4,5-Dimetoksy-2-bromfenetylamin | 63375-81-5 |
| 4-AcO-DET | 1135424-15-5 |
| 4-AcO-DiPT | 936015-60-0 |
| 4-AcO-DMT | 92292-84-7 |
| 4-AcO-EPT (4-acetoksy-N-etyl-N-propyltryptamin) | Forbudt etter § 5 | 2750249-90-0 |
| 4-AcO-MET | Forbudt etter § 5 | 1445751-40-5 |
| 4-AcO-MiPT | 1024612-25-6 |
| 4-AcO-MPT (4-acetoksy-N-metyl-N-propyltryptamin) | Forbudt etter § 5 | 2173386-55-3 |
| 4-BMC | Forbudt etter § 5 | 486459-03-4 |
| 4-Bromfentanyl (para-bromfentanyl) | Forbudt etter § 5 | 117994-23-7 |
| 4Br-α-PPP | Forbudt etter § 5 | 1152859-02-3 |
| 4Br-α-PVP | Forbudt etter § 5 | 850352-17-9 (HCl-salt) |
| 4-CA | Forbudt etter § 5 | 64-12-0 |
| 4-CBC | Forbudt etter § 5 | – |
| 4C-D (ariadne, α-Et-2C-D, 4C-DOM, dimoksamin) | Forbudt etter § 5 | 52842-59-8 |
| 4-CEC | Forbudt etter § 5 | 14919-85-8 |
| 4-CIC | Forbudt etter § 5 | – |
| 4-Cl-3-MMC (4-klor-3-metylmetkatinon) | Forbudt etter § 5 | 15861-86-6 |
| 4-CMA | Forbudt etter § 5 | 30572-91-9 |
| 4-CMC (klefedron) | P II | Forbudt etter § 5 | 1225843-86-6 |
| 4-EEC | Forbudt etter § 5 | 1225619-32-8 |
| 4-EMC; se 4-etylmetkatinon | 1225622-14-9 |
| 4-Etylmetkatinon | Forbudt etter § 5 | 1225622-14-9 |
| 4-Etyl-α-PVP | Forbudt etter § 5 | – |
| 4F-3-metyl-α-PHP (4-fluor-3-metyl-α-pyrrolidinoheksanophenon) | Forbudt etter § 5 | – |
| 4-FEC | Forbudt etter § 5 | 1225625-74-0 |
| 4-Fenylfentanyl | Forbudt etter § 5 | 120448-97-7 |
| 4-FIBF | N I | Forbudt etter § 5 | 244195-32-2 |
| 4-Fluoramfetamin (4-FA) | P II | Forbudt etter § 5 | 459-02-9 |
| 4-Fluorbufedron | Forbudt etter § 5 | 2624137-27-3 (HCl-salt) |
| 4-Fluorbutyrfentanyl (4-FBF) | N I | Forbudt etter § 5 | 244195-31-1 |
| 4-Fluoretylamfetamin | Forbudt etter § 5 | 3823-30-1 |
| 4-Fluorisobutyrfentanyl; se 4-FIBF | 244195-32-2 |
| 4-Fluormetoksyacetylfentanyl | Forbudt etter § 5 | – |
| 4-Fluor-N-isopropylpentedron | Forbudt etter § 5 | – |
| 4-Fluorpentedron | Forbudt etter § 5 | 2131054-74-3 |
| 4-FMA | Forbudt etter § 5 | 351-03-1 |
| 4-FMC (flefedron) | 447-40-5 |
| 4F-MDMB-BINACA | P II | Forbudt etter § 5 | 2390036-46-9 |
| 4F-NEB | Forbudt etter § 5 | – |
| 4F-NEP | Forbudt etter § 5 | – |
| 4F-PBP | Forbudt etter § 5 | 1373918-67-2 |
| 4F-α-PHiP | Forbudt etter § 5 | – |
| 4F-α-PHP | Forbudt etter § 5 | 2230706-09-7 |
| 4F-α-POP | Forbudt etter § 5 | 1829588-09-1 |
| 4F-α-PVP | Forbudt etter § 5 | 850352-62-4 |
| 4F-α-PVP piperidinanalog | Forbudt etter § 5 | 2131057-86-6 |
| 4-HO-DET | 22204-89-3 |
| 4-HO-DPT (4-hydroksy-N,N-dipropyltryptamin, deprocin) | Forbudt etter § 5 | 63065-88-3 |
| 4-HO-EPT (4-hydroksy-N-etyl-N-propyltryptamin, eprocin) | Forbudt etter § 5 | 2595431-59-5 |
| 4-HO-McPT 4-hydroksy-N-metyl-N-syklopropyltryptamin | Forbudt etter § 5 | 2883663-05-4 |
| 4-HO-MET | 77872-41-4 |
| 4-HO-MiPT | 77872-43-6 |
| 4-HO-MPT (4-hydroksy-N-metyl-N-propyltryptamin, meprocin) | Forbudt etter § 5 | 763035-03-6 |
| 4-Hydroksy DiPT (4-OH DiPT, 4-HO DiPT, iprocin) | Forbudt etter § 5 | 132328-45-1 |
| 4-Hydroksymetkatinon | Forbudt etter § 5 | – |
| 4'-Hydroksynitazen (O-desalkyl isotonitazen) | Forbudt etter § 5 | 94758-81-3 |
| 4-Klorisobutyrylfentanyl | Forbudt etter § 5 | 244195-34-4 |
| 4-Klor-N,N-DMC (4-klor-N,N-dimetylkatinon) | Forbudt etter § 5 | 2493977-47-0 (HCl-salt) |
| 4-Klor-N-etylamfetamin | Forbudt etter § 5 | 2275-67-4 |
| 4-Klorpentedron | Forbudt etter § 5 | – |
| 4-Klor-α-PHP (4-klor-PHP, 4-klor-α-pyrrolidinoheksanofenon, 4-Cl-PHP) | Forbudt etter § 5 | 2748592-28-9 |
| 4-Klor-α-PPP | Forbudt etter § 5 | 28117-79-5 |
| 4-Klor-α-PVP | Forbudt etter § 5 | 5881-77-6 |
| 4-MA | 64-11-9 |
| 4-MBC; se benzedron | 1225617-75-3 |
| 4-MC (4-metylkatinon, normefedron) | Forbudt etter § 5 | 31952-47-3 |
| 4-MEC | P II | Forbudt etter § 5 | 1225617-18-4 |
| 4-MeMABP | Forbudt etter § 5 | 1336911-98-8 |
| 4-MeO-DMT; se 4-metoksy-DMT | 3965-97-7 |
| 4-MeO-MiPT (4-metoksy-N-metyl-N-isoproyltryptamin) | Forbudt etter § 5 | 96096-53-6 |
| 4-MeOPBP | Forbudt etter § 5 | – |
| 4-MeO-α-PVP | Forbudt etter § 5 | 14979-97-6 |
| 4-Metoksy PV8 (para-MeO-PV8, 4-metoksy-α-PHPP) | Forbudt etter § 5 | 1801552-04-4 |
| 4-Metoksy PV9 (4-metoksy-α-POP) | Forbudt etter § 5 | 1800098-37-6 |
| 4-Metoksybutyrylfentanyl | Forbudt etter § 5 | 2088842-68-4 |
| 4-Metoksy-DMT | Forbudt etter § 5 | 3965-97-7 |
| 4-Metoksyetkatinon | Forbudt etter § 5 | 1225845-30-6 |
| 4-Metoksyfuranylfentanyl (para- metoksyfuranylfentanyl) | Forbudt etter § 5 | – |
| 4-Metoksy-N,N-dimetyltryptamin; se 4-metoksy-DMT | 3965-97-7 |
| 4-Metylbufedron; se 4-MeMABP | 1336911-98-8 |
| 4'-Metylheksedron | Forbudt etter § 5 | 2168553-84-0 |
| 4-Metylmetkatinon (mefedron) | P II | Forbudt etter § 5 | 1189805-46-6 |
| 4'-Metyl-N-isopropylpentedron (4'-metyl-NiPP) | Forbudt etter § 5 | 788094-23-5 |
| 4-Metyl-α-etylaminopentiofenon | Forbudt etter § 5 | 746540-82-9 |
| 4'-Metyl-α-PiHP | Forbudt etter § 5 | 850352-51-1 |
| 4'-Metyl-α-pyrrolidinobutiofenon (MPBP) | Forbudt etter § 5 | 732180-91-5 |
| 4-MMA | Forbudt etter § 5 | 714965-56-7 |
| 4-MPD | Forbudt etter § 5 | 1373918-61-6 |
| 4-MTA | P I | Forbudt etter § 5 | 14116-06-4 |
| 4-Propoksy-3,5-DMPEA (proskalin) | Forbudt etter § 5 | 39201-78-0 |
| 5-AcO-DET | Forbudt etter § 5 | – |
| 5-DBFPV | Forbudt etter § 5 | 2117405-32-8 |
| 5F-ADB; se 5F-MDMB-PINACA | 1715016-75-3 |
| 5F-AMB; se 5F-AMB-PINACA | 1715016-74-2 |
| 5F-AMB-PINACA | P II | Forbudt etter § 5 | 1715016-74-2 |
| 5F-APINACA | P II | Forbudt etter § 5 | 1400742-13-3 |
| 5F-JWH-398 (CL-2201, 4'-kloro-AM-2201, JWH-398 N-fluorpentyl) analog, SGT-20) | Forbudt etter § 5 | 1391486-12-6 |
| 5''-Fluor JWH-210; se EAM-2201 | 1364933-60-7 |
| 5F-MDMB-2201; se 5F-MDMB-PICA | 1971007-88-1 |
| 5F-MDMB-PICA | P II | Forbudt etter § 5 | 1971007-88-1 |
| 5F-MDMB-PINACA | P II | Forbudt etter § 5 | 1715016-75-3 |
| 5F-MMB-PINACA; se 5F-AMB-PINACA | 1715016-74-2 |
| 5F-PB-22 | P II | Forbudt etter § 5 | 1400742-41-7 |
| 5-IT | Forbudt etter § 5 | 3784-30-3 |
| 5-MAPDB | Forbudt etter § 5 | 1354631-78-9 |
| 5-MAPDI | Forbudt etter § 5 | 1310153-27-5 |
| 5-MeO-DBT (5-MeO BET, 5-metoksy-N,N-dibutyltryptamin) | Forbudt etter § 5 | 73785-42-9 |
| 5-MeO-DiPT | 4021-34-5 |
| 5-MeO-DMT | 1019-45-0 |
| 5-MeO-EiPT | Forbudt etter § 5 | 850032-66-5 |
| 5-MeO-MET | 16977-53-0 |
| 5-MeO-MiPT | 96096-55-8 |
| 5-Metoksymetylon; se bk-MMDMA | 2230716-98-8 |
| 6-AcO-DET | Forbudt etter § 5 | – |
| 6-MAM | 2784-73-8 |
| 6-Metoksy-MDA (MMDA-2) | Forbudt etter § 5 | 23693-18-7 |
| 6-Nikotinoylmorfin (6-mononikotinoylmorfin, morfin 6-nikotinat) | Forbudt etter § 5 | 75533-60-7 |
| 7-AcO-DET | Forbudt etter § 5 | – |
| 7-hydroksymitragynin (7-HMG) | Forbudt etter § 5 | 174418-82-7 |
| α-dimetylaminopentiofenon | Forbudt etter § 5 | 2168229-67-0 |
| α-EPP (α-EAPP) | Forbudt etter § 5 | 779974-89-9 |
| α-Metyl butyryl fentanyl (2-metyl butyryl fentanyl) | Forbudt etter § 5 | 2748591-35-5 (HCl-salt) |
| α-metylfentanyl | N I+IV | Forbudt etter § 5 | 79704-88-4 |
| α-metyltiofentanyl | N I+IV | Forbudt etter § 5 | 103963-66-2 |
| α-PBP | 13415-82-2 |
| α-PEP (α-PHPP, heptiofenon, PV-8) | Forbudt etter § 5 | 13415-83-3 |
| α-PHP | P II | Forbudt etter § 5 | 13415-86-6 |
| α-PHPP (α-PEP, heptiofenon, PV-8) | Forbudt etter § 5 | 13415-83-3 |
| α-PiHP | P II | Forbudt etter § 5 | 2181620-71-1 |
| α-PNP | Forbudt etter § 5 | 13415-58-2 |
| α-POP (PV9) | Forbudt etter § 5 | – |
| α-PPP | Forbudt etter § 5 | 19134-50-0 |
| α-PVP | P II | Forbudt etter § 5 | 14530-33-7 |
| α-TMT | Forbudt etter § 5 | 4761-32-4 |
| AB-CHMINACA | P II | Forbudt etter § 5 | 1185887-21-1 |
| AB-FUBINACA | P II | Forbudt etter § 5 | 1185282-01-2 |
| AB-PINACA | P II | Forbudt etter § 5 | 1445752-09-9 |
| Acetorfin | N I | Forbudt etter § 5 | 25333-77-1 |
| Acetyldihydrokodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 3861-72-1 |
| Acetylfentanyl | N I+IV | Forbudt etter § 5 | 3258-84-2 |
| Acetylmetadol | N I | 509-74-0 |
| Acetyl-α-metylfentanyl | N I+IV | Forbudt etter § 5 | 101860-00-8 |
| ADB-BUTINACA | P II | Forbudt etter § 5 | 2666932-43-8 |
| ADB-CHMINACA | P II | Forbudt etter § 5 | 1185887-13-1 |
| ADB-FUBINACA | P II | Forbudt etter § 5 | 1445583-51-6 |
| AH-7921 | N I | Forbudt etter § 5 | 55154-30-8 |
| Akrylfentanyl; se akryloylfentanyl | 82003-75-6 |
| Akryloylfentanyl | N I | Forbudt etter § 5 | 82003-75-6 |
| Alfacetylmetadol | N I | 17199-58-5 |
| Alfameprodin | N I | 468-51-9 |
| Alfametadol | N I | 17199-54-1 |
| Alfaprodin | N I | 77-20-3 |
| Alfentanil | N I | 71195-58-9 |
| Allobarbital | P IV | 52-43-7 |
| Allyleskalin | 39201-75-7 |
| Allylprodin | N I | 25384-17-2 |
| Alprazolam | P IV | 28981-97-7 |
| AM-2201 | P II | Forbudt etter § 5 | 335161-24-5 |
| AM-2201 2-hydroksyindol metabolitt | Forbudt etter § 5 | 2749391-49-7 |
| AM-2201 5-hydroksyindol metabolitt | Forbudt etter § 5 | – |
| AM-2201 6-hydroksyindol metabolitt | Forbudt etter § 5 | 1427521-35-4 |
| AM-2201 7-hydroksyindol metabolitt | Forbudt etter § 5 | 1537889-11-4 |
| AM-2201 kloranalog | – |
| AM-2201 N-(3-fluorpentyl) isomer | Forbudt etter § 5 | – |
| AM-679 | Forbudt etter § 5 | 335160-91-3 |
| AM-694 | 335161-03-0 |
| AMB-FUBINACA; se FUB-AMB | 1715016-76-4 |
| Amfepramon | P IV | 134-80-5 |
| Amfetamin | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 300-62-9 |
| Amineptin | P II | 57574-09-1 |
| Aminorex | P IV | Forbudt etter § 5 | 2207-50-3 |
| Amobarbital | P III | 57-43-2 |
| Anileridin | N I | 144-14-9 |
| Aprobarbital | 77-02-1 |
| β-hydroksy-3-metylfentanyl (ohmefentanyl) | N I+IV | Forbudt etter § 5 | 78995-14-9 |
| β-hydroksyfentanyl | N I+IV | Forbudt etter § 5 | 78995-10-5 |
| β-hydroksytiofentanyl | Forbudt etter § 5 | 1474-34-6 |
| β-metylfentanyl | Forbudt etter § 5 | 79146-56-8 |
| Barbital | P IV | 57-44-3 |
| BDB | Forbudt etter § 5 | 107447-03-0 |
| Bentazepam | 29462-18-8 |
| Benzedron (4-MBC) | Forbudt etter § 5 | 1225617-75-3 |
| Benzetidin | N I | 3691-78-9 |
| Benzfetamin | P IV | Forbudt etter § 5 | 156-08-1 |
| Benzoylekgonin | N I | 519-09-5 |
| Benzoylfentanyl | Forbudt etter § 5 | 2309383-15-9 |
| Benzylmorfin | N I | 14297-87-1 |
| Betacetylmetadol | N I | 17199-59-6 |
| Betameprodin | N I | 468-50-8 |
| Betametadol | N I | 17199-55-2 |
| Betaprodin | N I | 468-59-7 |
| Bezitramid | N I | 15301-48-1 |
| bk-3,4-MDPA (propylon) | Forbudt etter § 5 | 201474-93-3 |
| bk-6-metoksy-MDMA | Forbudt etter § 5 | – |
| bk-DMBDB (dibutylon) | 802286-83-5 |
| bk-EBDB (eutylon) | P II | Forbudt etter § 5 | 802855-66-9 |
| bk-IMP | Forbudt etter § 5 | 100608-69-3 |
| bk-IVP | Forbudt etter § 5 | – |
| bk-MBDB (butylon) | Forbudt etter § 5 | 802575-11-7 |
| bk-MDDMA (dimetylon) | 765231-58-1 |
| bk-MDEA (etylon) | P II | Forbudt etter § 5 | 1112937-64-0 |
| bk-MDMA (metylon) | P II | Forbudt etter § 5 | 186028-79-5 |
| bk-MMDMA (5-metoksymetylon) | Forbudt etter § 5 | 2230716-98-8 |
| bk-PBDB (putylon) | 802286-81-3 |
| bk-PMMA (metedron) | 530-54-1 |
| BMDB | Forbudt etter § 5 | 1823865-05-9 (HCl-salt) |
| BMDP (benzylon) | Forbudt etter § 5 | 1823274-68-5 |
| Brifentanil (brifentanyl, A-3331) | Forbudt etter § 5 | 101345-71-5 |
| Brolamfetamin (DOB) | P I | Forbudt etter § 5 | 64638-07-9 |
| Bromazepam | P IV | 1812-30-2 |
| Bromazolam | P IV | Forbudt etter § 5 | 71368-80-4 |
| Brombenzo-difuranyl-isopropylamin (bromo-DragonFLY) | Forbudt etter § 5 | 502759-67-3 |
| Brorfin | N I | Forbudt etter § 5 | 2244737-98-0 |
| Brotizolam | P IV | 57801-81-7 |
| Bufedron; se MABP | 408332-79-6 |
| Bufotenin (5-HO-DMT) | Forbudt etter § 5 | 487-93-4 |
| Buprenorfin | P III | 52485-79-7 |
| Butalbital | P III | 77-26-9 |
| Butobarbital | P IV | 77-28-1 |
| Butonitazen (butoksynitazen) | N I | Forbudt etter § 5 | 95810-54-1 |
| Butylon; se bk-MBDB | 802575-11-7 |
| Butyrfentanyl (butyrylfentanyl) | N I | Forbudt etter § 5 | 1169-70-6 |
| Camazepam | P IV | 36104-80-0 |
| Cannabis (med cannabis menes de overjordiske deler av alle vekster av slekten cannabis (unntatt frøene), hvis harpiksen ikke er ekstrahert) | N I+IV | Forbudt etter § 5 |
| Cannabisharpiks | N I+IV | Forbudt etter § 5 |
| Catha edulis (khat) | Forbudt etter § 5 |
| Clobazam | P IV | 22316-47-8 |
| Clobenzorex | 13364-32-4 |
| Clotiazepam | P IV | 33671-46-4 |
| Cloxazolam | P IV | 24166-13-0 |
| Cocablad | N I |
| Codeine Impurity D (EP) (3-O-(kodein-2-yl)morfin) | Forbudt etter § 5 | 2585669-81-2 |
| Codoxim | N I | 7125-76-0 |
| CP 47,497 | 70434-82-1 |
| CP 47,497-C8-homolog | Forbudt etter § 5 | 70434-92-3 |
| CP 55,940 | Forbudt etter § 5 | 83002-04-4 |
| CUMYL-4CN-BINACA | P II | Forbudt etter § 5 | 1631074-54-8 |
| CUMYL-PEGACLONE | P II | Forbudt etter § 5 | 2160555-55-3 |
| Dekstroamfetamin (Dexamfetamine) | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 51-64-9 |
| Dekstropropoksifen | N I+III | Unntak fra sertifikatkrav, se § 10 | 469-62-5 |
| Delorazepam | P IV | 2894-67-9 |
| delta-6a(7)-THC; se tetrahydrocannabinol | 59042-44-3 |
| delta-6a(10a)-THC; se tetrahydrocannabinol | 7663-50-5 |
| delta-7-THC; se tetrahydrocannabinol | 42793-13-5 |
| delta-8-THC; se tetrahydrocannabinol | 5957-75-5 |
| delta8-THC acetat (Δ8-tetrahydrocannabinol acetat, Δ8-THC-O-acetat) | Forbudt etter § 5 | 23050-54-6 |
| delta-9-tetrahydrocannabinol; se dronabinol | 1972-08-3 |
| delta9-THC acetat (Δ9-tetrahydrocannabinol acetat, THC-O-acetat) | Forbudt etter § 5 | 23132-17-4 |
| delta-9(11)-THC; se tetrahydrocannabinol | 27179-28-8 |
| delta-10-THC; se tetrahydrocannabinol | 7663-51-6 |
| Desomorfin | N I+IV | Forbudt etter § 5 | 427-00-9 |
| DET | P I | Forbudt etter § 5 | 61-51-8 |
| Dextromoramid | N I | 357-56-2 |
| Diacetylmorfin; se heroin | 561-27-3 |
| Diampromid | N I | 552-25-0 |
| Diazepam | P IV | 439-14-5 |
| Dibutylon; se bk-DMBDB | 802286-83-5 |
| Diclazepam | P IV | Forbudt etter § 5 | 2894-68-0 |
| Dietyltiambuten | N I | 86-14-6 |
| Difenidin | P II | Forbudt etter § 5 | 36794-52-2 |
| Difenoksin | N I | 28782-42-5 |
| Difenoksylat | N I+III | Unntak fra sertifikatkrav, se § 10 | 915-30-0 |
| Dihydroetorfin | N I | 14357-76-7 |
| Dihydrokodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 125-28-0 |
| Dihydromorfin | N I | 509-60-4 |
| Dimenoxadol | N I | 509-78-4 |
| Dimepheptanol | N I | 545-90-4 |
| Dimetyltiambuten | N I | 524-84-5 |
| Dioksafetylbutyrat | N I | 467-86-7 |
| Dipipanon | N I | 467-83-4 |
| DiPT | 14780-24-6 |
| DL-4662 | Forbudt etter § 5 | – |
| DMA (2,5-DMA) | P I | Forbudt etter § 5 | 2801-68-5 |
| DMHP | P I | Forbudt etter § 5 | 32904-22-6 |
| DMT | P I | Forbudt etter § 5 | 61-50-7 |
| D-norpseudoefedrin; se katin | 492-39-7 |
| DOB; se brolamfetamin | 64638-07-9 |
| DOC | P I | Forbudt etter § 5 | 123431-31-2 |
| DOET | P I | Forbudt etter § 5 | 22004-32-6 |
| DOI | 42203-78-1 |
| DOM | P I | Forbudt etter § 5 | 15588-95-1 |
| DOPR | Forbudt etter § 5 | 63779-88-4 |
| DOT (Aleph) | Forbudt etter § 5 | 61638-07-1 |
| DPT | 61-52-9 |
| Dronabinol | P II | Forbudt etter § 5 | 1972-08-3 |
| Drotebanol | N I | 3176-03-2 |
| EAM-2201 (5-fluor JWH-210) | Forbudt etter § 5 | 1364933-60-7 |
| Efylon; se N-etylpentylon | 727641-67-0 |
| Ekgonin | N I | 481-37-8 |
| Eskalin | 39201-82-6 |
| Esketamin (S-ketamin) | 33643-46-8 |
| Estazolam | P IV | 29975-16-4 |
| Eszopiklon (S-zopiklon) | 138729-47-2 |
| Etazen | N I | Forbudt etter § 5 | 14030-76-3 |
| Eticyclidin (PCE) | P I | Forbudt etter § 5 | 2201-15-2 |
| Etilamfetamin | P IV | 457-87-4 |
| Etinamat | P IV | 126-52-3 |
| Etizolam | P IV | 40054-69-1 |
| Etkatinon (N-etylkatinon) | 18259-37-5 |
| Etklorvynol | P IV | 113-18-8 |
| Etometazen (5-metyl etodesnitazen, 5-metyldesnitroetonitazen, eto) | Forbudt etter § 5 | 95293-25-7 |
| Etonitazen | N I | 911-65-9 |
| Etonitazepipne (N-piperidino etonitazen) | N I | Forbudt etter § 5 | 734496-28-7 |
| Etonitazepyn | N I | Forbudt etter § 5 | – |
| Etorfin | N I | Forbudt etter § 5 | 14521-96-1 |
| Etoxeridin | N I | 469-82-9 |
| Etryptamin | P I | Forbudt etter § 5 | 2235-90-7 |
| Etyl morfin 6-β-D-glukuronid | Forbudt etter § 5 | 168074-32-6 |
| Etylfenidat | P II | Forbudt etter § 5 | 57413-43-1 |
| Etylloflazepat | P IV | 29177-84-2 |
| Etylmetyltiambuten | N I | 441-61-2 |
| Etylmorfin | N II+III | Unntak fra sertifikatkrav, se § 10 | 76-58-4 |
| Etylmorfin-6-glukuronid | Forbudt etter § 5 | – |
| Etylon (bk-MDEA) | P II | Forbudt etter § 5 | 1112937-64-0 |
| Etylpropyltryptamin (N-etyl-N-propyltryptamin, EPT) | Forbudt etter § 5 | 850032-68-7 |
| Eutylon; se bk-EBDB | 802855-66-9 |
| Fenadokson | N I | 467-84-5 |
| Fenampromid | N I | 129-83-9 |
| Fenaridin (2,5-dimetylfentanyl) | Forbudt etter § 5 | 42045-97-6 |
| Fenazepam | P IV | 51753-57-2 |
| Fenazokin | N I | 127-35-5 |
| Fencamfamin | P IV | 1209-98-9 |
| Fendimetrazin | P IV | Forbudt etter § 5 | 634-03-7 |
| Fenetyllin | P II | Forbudt etter § 5 | 3736-08-1 |
| Fenfluramin | 458-24-2 |
| Fenibut (Phenibut) | 1078-21-3 |
| Fenmetrazin | P II | 134-49-6 |
| Fenobarbital | P IV | 50-06-6 |
| Fenomorfan | N I | 468-07-5 |
| Fenoperidin | N I | 562-26-5 |
| Fenproporex | P IV | 16397-28-7 |
| Fensyklidin (PCP) | P II | Forbudt etter § 5 | 77-10-1 |
| Fentanyl | N I | 437-38-7 |
| Fentermin | P IV | Forbudt etter § 5 | 122-09-8 |
| Flefedron; se 4-FMC | 447-40-5 |
| Flualprazolam | P IV | 28910-91-0 |
| Flubromazolam | P IV | Forbudt etter § 5 | 612526-40-6 |
| Fludiazepam | P IV | 3900-31-0 |
| Flunitazen (fluonitazen) | Forbudt etter § 5 | 2249-36-7 |
| Flunitrazepam | P III | 1622-62-4 |
| Flurazepam | P IV | 17617-23-1 |
| Folkodin | N II + III | Unntak fra sertifikatkrav, se § 10 | 509-67-1 |
| FUB-AMB (AMB-FUBINACA, MMB-FUBINACA) | P II | Forbudt etter § 5 | 1715016-76-4 |
| Furanyletylfentanyl | Forbudt etter § 5 | 802544-02-1 |
| Furanylfentanyl | N I | Forbudt etter § 5 | 101345-66-8 |
| Furetidin | N I | 2385-81-1 |
| Gammabutyrolakton (GBL) | 96-48-0 |
| Gammahydroksybutyrat (GHB) | P II | 591-81-1 |
| Glutetimid | P III | 77-21-4 |
| Halazepam | P IV | 23092-17-3 |
| Haloksazolam | P IV | 59128-97-1 |
| Heksedron; se 2-(metylamino)-1-fenylheksan-1-on | 2169446-41-5 |
| Heksobarbarbital | 56-29-1 |
| Heksylon | – |
| Heptabarbital (heptabarb) | 509-86-4 |
| Heroin | N I+IV | Forbudt etter § 5 | 561-27-3 |
| Hexahydrocannabinol (HHC) | P II | Forbudt etter § 5 | 6692-85-9 |
| Hydrokodon | N I | 125-29-1 |
| Hydroksypetidin | N I | 468-56-4 |
| Hydromorfinol | N I | 2183-56-4 |
| Hydromorfon | N I | 466-99-9 |
| Iso-butonitazen | Forbudt etter § 5 | – |
| Isobutyrylfentanyl (isobutyrfentanyl) | Forbudt etter § 5 | 119618-70-1 |
| Isoheksedron (α-methylaminoisoheksanofenon) | Forbudt etter § 5 | – |
| Isoheksylon (3,4-metylendioksy-α-metylaminoisoheksanofenon) | Forbudt etter § 5 | 1157947-89-1 |
| Isometadon | N I | 466-40-0 |
| Isotonitazen | N I | Forbudt etter § 5 | 14188-81-9 |
| JWH-007 | 155471-10-6 |
| JWH-011 | 155471-13-9 |
| JWH-015 | 155471-08-2 |
| JWH-016 | 155471-09-3 |
| JWH-018 | P II | Forbudt etter § 5 | 209414-07-3 |
| JWH-018 2-hydroksyindol metabolitt | Forbudt etter § 5 | 1427325-32-3 |
| JWH-019 | 209414-08-4 |
| JWH-020 | 209414-09-5 |
| JWH-022 | 209414-16-4 |
| JWH-030 | 162934-73-8 |
| JWH-031 | 162934-74-9 |
| JWH-047 | 316189-65-8 |
| JWH-048 | 316189-66-9 |
| JWH-071 | 209414-05-1 |
| JWH-072 | 209414-06-2 |
| JWH-073 | Forbudt etter § 5 | 208987-48-8 |
| JWH-081 | Forbudt etter § 5 | 210179-46-7 |
| JWH-098 | 316189-74-9 |
| JWH-116 | 619294-64-3 |
| JWH-120 | 824955-98-8 |
| JWH-122 | Forbudt etter § 5 | 619294-47-2 |
| JWH-122N-(4-pentenyl) analog (MAM2201 N-(4-pentenyl) analog, JWH 022 4-metylnaftyl analog) | Forbudt etter § 5 | 1445577-68-3 |
| JWH-122N-(5-brompentyl) analog | Forbudt etter § 5 | – |
| JWH-122N-(5-iodpentyl) analog | Forbudt etter § 5 | – |
| JWH-145 | 914458-19-8 |
| JWH-147 | 914458-20-1 |
| JWH-148 | 824955-99-9 |
| JWH-149 | 548461-82-1 |
| JWH-164 | 824961-61-7 |
| JWH-166 | 824961-41-3 |
| JWH-167 | 864445-37-4 |
| JWH-171 | – |
| JWH-175 | 619294-35-8 |
| JWH-176 | 619294-62-1 |
| JWH-180 | 824959-87-7 |
| JWH-181 | 824960-03-4 |
| JWH-182 | 824960-02-3 |
| JWH-184 | 619294-37-0 |
| JWH-185 | 619294-39-2 |
| JWH-192 | – |
| JWH-193 | 133438-58-1 |
| JWH-194 | – |
| JWH-195 | – |
| JWH-196 | 619294-41-6 |
| JWH-197 | – |
| JWH-198 | 166599-76-4 |
| JWH-199 | – |
| JWH-200 | 103610-04-4 |
| JWH-201 | 864445-47-6 |
| JWH-203 | Forbudt etter § 5 | 864445-54-5 |
| JWH-205 | – |
| JWH-210 | Forbudt etter § 5 | 824959-81-1 |
| JWH-250 | Forbudt etter § 5 | 864445-43-2 |
| JWH-251 | 864445-39-6 |
| JWH-302 | Forbudt etter § 5 | 864445-45-4 |
| JWH-307 | Forbudt etter § 5 | 914458-26-7 |
| JWH-308 | Forbudt etter § 5 | – |
| JWH-309 | Forbudt etter § 5 | 914458-42-7 |
| JWH-368 | Forbudt etter § 5 | 914458-31-4 |
| JWH-369 | Forbudt etter § 5 | 914458-27-8 |
| JWH-398 | 1292765-18-4 |
| Karfentanil | N I+IV | Forbudt etter § 5 | 59708-52-0 |
| Karisoprodol (carisoprodol) | P IV | 78-44-4 |
| Katin (D-norpseudoefedrin) | P III | 492-39-7 |
| Katinon | P I | Forbudt etter § 5 | 71031-15-7 |
| Ketamin | 6740-88-1 |
| Ketazolam | P IV | 27223-35-4 |
| Ketobemidon | N I+IV | 469-79-4 |
| Khat; se Catha edulis |
| Klefedron; se 4-CMC | 1225843-86-6 |
| Klofedron; se 3-CMC | P II | 1049677-59-9 |
| Klonazepam | P IV | 1622-61-3 |
| Klonazolam | P IV | Forbudt etter § 5 | 33887-02-4 |
| Klonitazen | N I | 3861-76-5 |
| Klorazepat | P IV | 23887-31-2 |
| Klordiazepoksid | P IV | 58-25-3 |
| Klorfentermin | Forbudt etter § 5 | 461-78-9 |
| Kodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 76-57-3 |
| Kodein-N-oksid | 3688-65-1 |
| Koka-blad; se cocablad |
| Kokain | N I | 50-36-2 |
| Kratom (Mitragyna speciosa) | Forbudt etter § 5 |
| Krotonylfentanyl | N I | Forbudt etter § 5 | 760930-59-4 |
| Lefetamin | P IV | Forbudt etter § 5 | 7262-75-1 |
| Levoamfetamin (levamfetamin) | P II | Forbudt etter § 5 | 156-34-3 |
| Levofenacylmorfan | N I | 10061-32-2 |
| Levometamfetamin | P II | Forbudt etter § 5 | 33817-09-3 |
| Levometorfan | N I | 125-70-2 |
| Levomoramid | N I | 5666-11-5 |
| Levorfanol | N I | 77-07-6 |
| Lisdeksamfetamin | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 608137-32-2 |
| Lofentanil (lofentanyl) | Forbudt etter § 5 | 61380-40-3 |
| Loprazolam | P IV | 61197-73-7 |
| Lorazepam | P IV | 846-49-1 |
| Lormetazepam | P IV | 848-75-9 |
| LSD; se lysergide | 50-37-3 |
| Lysergide | P I | Forbudt etter § 5 | 50-37-3 |
| MAB-CHMINACA; se ADB-CHMINACA | 1185887-13-1 |
| MABP (bufedron) | 408332-79-6 |
| MAL (metallyleskalin) | Forbudt etter § 5 | 207740-41-8 |
| MAM-2201 | 1354631-24-5 |
| MAM-2201 N-(3-fluorpentyl) analog | Forbudt etter § 5 | – |
| MAM-2201 N-(5-klorpentyl) analog | Forbudt etter § 5 | 1445578-25-5 |
| Mazindol | P IV | Forbudt etter § 5 | 22232-71-9 |
| MBDB | Forbudt etter § 5 | 135795-90-3 |
| mCPP; se 1-(3-klorfenyl)-piperazin | 6640-24-0 |
| MDA; se tenamfetamin | 4764-17-4 |
| MDMA (ecstacy) | P I | Forbudt etter § 5 | 42542-10-9 |
| MDMB-4en-PINACA | P II | Forbudt etter § 5 | 2504100-70-1 |
| MDMB-CHMICA | P II | Forbudt etter § 5 | 1863065-84-2 |
| MDPHP; se 3',4'-MDPHP | 776994-64-0 |
| MDPPP | Forbudt etter § 5 | 783241-66-7 |
| MDPT(tBuONE) (D-tertylon) | Forbudt etter § 5 | 2469270-98-0 (HCl-salt) |
| MDPV | P II | Forbudt etter § 5 | 687603-66-3 |
| Mecloqualon | P II | 340-57-8 |
| Medazepam | P IV | 2898-12-6 |
| Mefedron; se 4-metylmetkatinon | 1189805-46-6 |
| Mefenorex | P IV | 17243-57-1 |
| Menitazen (Metylnitazen) | Forbudt etter § 5 | 95282-00-1 |
| Meprobamat | P IV | 57-53-4 |
| Meskalin | P I | Forbudt etter § 5 | 54-04-6 |
| Mesocarb | P IV | Forbudt etter § 5 | 34262-84-5 |
| MET | 5599-69-9 |
| Metadon | N I | 76-99-3 |
| Metadon-intermediat | N I | 125-79-1 |
| Metafedrin (3-metylmetamfetamin, 3-MMA) | Forbudt etter § 5 | 861007-68-3 |
| Metafluorfentanyl; se 3-fluorfentanyl | – |
| Metakrylfentanyl | Forbudt etter § 5 | – |
| Metakvalon | P II | 72-44-6 |
| Metamfepramon (dimepropion, N,N-DMC, dimetylkatinon) | Forbudt etter § 5 | 15351-09-4 |
| Metamfetamin | P II | Forbudt etter § 5 | 537-46-2 |
| Metarbital | 50-11-3 |
| Metazocin | N I | 3734-52-9 |
| Metedron; se bk-PMMA | 530-54-1 |
| Metkatinon | P I | Forbudt etter § 5 | 5650-44-2 (R-form) 112117-24-5 (S-form) |
| Metodesnitazen (metazen) | Forbudt etter § 5 | 14030-77-4 |
| Metoheksital | 151-83-7 |
| Metoksetamin (MXE) | P II | Forbudt etter § 5 | 1239943-76-0 |
| Metoksyacetylfentanyl (MAF) | N I | Forbudt etter § 5 | 101345-67-9 |
| Metonitazen | N I | Forbudt etter § 5 | 14680-51-4 |
| Metopon | N I | 143-52-2 |
| Metylallyleskalin; se MAL | 207740-41-8 |
| Metylaminorex (4-metylaminorex) | P I | Forbudt etter § 5 | 3568-94-3 |
| Metyldesorfin | N I | Forbudt etter § 5 | 16008-36-9 |
| Metyldihydromorfin | N I | 509-56-8 |
| Metylendioksykatinon (3,4-metylendioksykatinon, MDC, nitrilon, amylon, βk-MDA) | Forbudt etter § 5 | 80535-73-5 |
| Metylfenidat | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 113-45-1 |
| Metylfenobarbital | P IV | 115-38-8 |
| Metylon; se bk-MDMA | 186028-79-5 |
| Metyprylon | P IV | 125-64-4 |
| MFPVP (4-fluor-3-metyl-α-pyrrolidinovalerofenon) | Forbudt etter § 5 | – |
| Midazolam | P IV | 59467-70-8 |
| Mitragynin | Forbudt etter § 5 | 4098-40-2 |
| MMB-FUBINACA; se FUB-AMB | 1715016-76-4 |
| MMDA | P I | Forbudt etter § 5 | 13674-05-0 |
| MMDA-2; se 6-metoksy-MDA | 23693-18-7 |
| MOPPP | Forbudt etter § 5 | 478243-09-3 |
| Moramid-intermediat | N I | 3626-55-9 |
| Morferidin | N I | 469-81-8 |
| Morfin | N I | 57-27-2 |
| Morfinmetobromid (morfinmetylbromid) og andre 5-verdige nitrogen-morfinderivater | N I | 125-23-5 |
| Morfin-N-oksid | N I | 639-46-3 |
| MPA (metiopropamin) | P II | Forbudt etter § 5 | 801156-47-8 |
| MPHP | Forbudt etter § 5 | 34138-58-4 |
| MPPP (4-MePPP) | Forbudt etter § 5 | 28117-80-8 |
| MPPP (desmetylprodin) | N I+IV | Forbudt etter § 5 | 13147-09-6 |
| MT-45 | N I | Forbudt etter § 5 | 41537-67-1 |
| Myrofin | N I | 467-18-5 |
| N,N-dietylheksedron(α -dietylaminoheksanofenon) | Forbudt etter § 5 | – |
| N,N-dietylpentylon | Forbudt etter § 5 | 801171-27-7 |
| N,N-dimetylpentylon (dipentylon) | P II | Forbudt etter § 5 | 803614-36-0 |
| N-butyl bufedron (N-butyl BP, NBB, α-butylaminobutiofenon, N-butyl norbufedron) | Forbudt etter § 5 | – |
| N-butylbutylon (N-butylnorbutylon, 3,4-metylendioksy-α-butylaminobutiofenon) | Forbudt etter § 5 | – |
| N-Butylheksedron (α-butylaminoheksanofenon) | Forbudt etter § 5 | 802576-87-0 |
| N-Butylheptedron | Forbudt etter § 5 | – |
| N-butyl-N-metyl butylon (3,4-metylendioksy-α-butylmetylaminobutiofenon) | Forbudt etter § 5 | – |
| N-butylpentylon (metylendioksybutylvalerofenon, MDBVP) | Forbudt etter § 5 | 688727-54-0 |
| N-desetyl etonitazen (NDE, noretonitazen) | Forbudt etter § 5 | 2732926-26-8 |
| N-desetylisotonitazen (norisotonitazen) | N I | Forbudt etter § 5 | 2732926-24-6 |
| NEB (N-etylbufedron) | 1354631-28-9 |
| N-etyl 2C-B | Forbudt etter § 5 | 155639-24-0 |
| N-etylamfetamin; se etilamfetamin | 457-87-4 |
| N-etylheksedron | P II | Forbudt etter § 5 | 802857-66-5 |
| N-Etylheksylon | Forbudt etter § 5 | 802605-02-3 |
| N-etylheptedron | Forbudt etter § 5 | – |
| N-etylheptylon | Forbudt etter § 5 | – |
| N-etylisoheksedron | Forbudt etter § 5 | – |
| N-etyl-N-metyl butylon (3,4-metylendioksy-α-etylmetylaminobutiofenon) | Forbudt etter § 5 | – |
| N-etylnorpentylon; se N-etylpentylon | 727641-67-0 |
| N-etylpentedron (NEP) | Forbudt etter § 5 | 779974-89-9 |
| N-etylpentylon (efylon) | P II | Forbudt etter § 5 | 727641-67-0 |
| N-etyltenamfetamin | P I | Forbudt etter § 5 | – |
| N-hydroksytenamfetamin (MDOH, MDH) | P I | Forbudt etter § 5 | 74698-47-8 |
| Nikodikodin (nikodikodein) | N II+III | Unntak fra sertifikatkrav, se § 10 | 808-24-2 |
| Nikokodin (nikokodein) | N II+III | Unntak fra sertifikatkrav, se § 10 | 3688-66-2 |
| Nikomorfin | N I | 639-48-5 |
| Nimetazepam | P IV | 2011-67-8 |
| N-isobutylheksedron (α-isobutylaminoheksanofenon, NDH) | Forbudt etter § 5 | – |
| Nitrazepam | P IV | 146-22-5 |
| N-Me-2C-B | Forbudt etter § 5 | – |
| N-Me-2C-H | Forbudt etter § 5 | 13063-01-9 (HCl-salt) |
| N-metyl-bk-MMDA-2; se bk-6-metoksy-MDMA | – |
| N-metyletylon (N-etylmetylon, 3,4-metylendioksy-N-etyl-N-metylkatinon) | Forbudt etter § 5 | 2703646-17-5 (HCl-salt) |
| N-metylheksylon; se heksylon | – |
| N-metyl-N-propyl metylon (3,4-metylendioksy-α-metylpropylaminopropiofenon, 3,4-metylendioksy-N-propylmetkatinon, N-propyl metylon, N-metyl propylon) | Forbudt etter § 5 | – |
| N-metyltryptamin (NMT) | 61-49-4 |
| NMT; se N-metyltryptamin | 61-49-4 |
| Noracymetadol | N I | 1477-39-0 |
| Nordazepam | P IV | 1088-11-5 |
| Norkodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 467-15-2 |
| Norkodein-6-glukuronid (norkodein-O-b-D-glukuronid) | Forbudt etter § 5 | – |
| Norlevorfanol | N I | 1531-12-0 |
| Normefedron; se 4-MC | 31952-47-3 |
| Normetadon | N I | 467-85-6 |
| Normorfin | N I | 466-97-7 |
| Norpipanon | N I | 561-48-8 |
| N-pentylmetylon (3,4-metylendioksy-N-pentylkatinon) | Forbudt etter § 5 | – |
| N-propyl bufedron (N-propylnorbufedron, N-propyl BP, NBP) | Forbudt etter § 5 | 18267-91-9 (HCl-salt) |
| N-propyl-N-metyl butylon (3,4-metylendioksy-α-propylmetylaminobutiofenon) | Forbudt etter § 5 | – |
| N-propylnorpentedron | Forbudt etter § 5 | – |
| N-pyrrolidino metonitazen (metonitazepyn) | N I | Forbudt etter § 5 | – |
| N-sec-butyl pentedron (2-(sec-butylamino)-valerofenon) | Forbudt etter § 5 | 18268-12-7 (HCl-salt) |
| Ocfentanil | N I | Forbudt etter § 5 | 101343-69-5 |
| Oksazepam | P IV | 604-75-1 |
| Oksazolam | P IV | 24143-17-7 |
| Oksykodon | N I | 76-42-6 |
| Oksymorfon | N I | 76-41-5 |
| Oksymorfon-3-β-D- glukuronid | Forbudt etter § 5 | 770735-01-8 |
| Opium | N I |
| Oripavin | N I | 467-04-9 |
| Ortofluorfentanyl; se 2-fluorfentanyl | 910616-29-4 |
| Orto-fluorfuranylfentanyl (2-fluor furanyl fentanyl) | Forbudt etter § 5 | 2749619-19-8 (HCl-salt) |
| Ortometylacetylfentanyl; se 2-metylacetylfentanyl | – |
| Panaeolus cyanescens (Blånende flekkskivesopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 |
| Para-bromamfetamin (PBA, 4-bromamfetamin (4-BA)) | Forbudt etter § 5 | 18455-37-3 |
| Parafluorbutyrfentanyl; se 4-fluorbutyrfentanyl | 244195-31-1 |
| Parafluorfentanyl | N I+IV | Forbudt etter § 5 | 90736-23-5 |
| Para-fluorfuranylfentanyl (4-fluor furanyl fentanyl) | Forbudt etter § 5 | 1802489-71-9 |
| Paraheksyl (synheksyl) | P I | Forbudt etter § 5 | 117-51-1 |
| Para-klor metoksyacetyl fentanyl (4-klormetoksyacetylfentanyl) | Forbudt etter § 5 | 101345-75-9 (HCl-salt) |
| Para-klorfentanyl | Forbudt etter § 5 | 117994-27-1 (HCl-salt) |
| Para-metoksy metoksyacetyl fentanyl | Forbudt etter § 5 | 2748289-90-7 (HCl-salt) |
| Parametoksyfuranylfentanyl; se 4-metoksyfuranylfentanyl | – |
| Parametoksymetamfetamin (PMMA) | P I | Forbudt etter § 5 | 22331-70-0 |
| Para-metylsyklopropylfentanyl (4-metyl syklopropyl fentanyl) | Forbudt etter § 5 | 2749910-43-6 (HCl-salt) |
| PCE; se eticyclidin | 2201-15-2 |
| PCPy; se rolicyclidin | 2201-39-0 |
| Pemolin | P IV | 2152-34-3 |
| Pentazocin | P III | 359-83-1 |
| Pentedron | P II | Forbudt etter § 5 | 879722-57-3 |
| Pentobarbital | P III | 76-74-4 |
| Pentylon | Forbudt etter § 5 | 698963-77-8 |
| PEPAP | N I+IV | Forbudt etter § 5 | 64-52-8 |
| Petidin – intermediat A, intermediat B (norpetidin), intermediat C (petidinsyre) | N I | 3627-62-1 77-17-8 3627-48-3 |
| Petidin (meperidin) | N I | 57-42-1 |
| Piminodin | N I | 13495-09-5 |
| Pinazepam | P IV | 52463-83-9 |
| Pipradrol | P IV | Forbudt etter § 5 | 467-60-7 |
| Piritramid | N I | 302-41-0 |
| PMA (para-metoksyamfetamin | P I | Forbudt etter § 5 | 64-13-1 |
| PMMA (4-MMA); se para-metoksymetamfetamin | 22331-70-0 |
| Poppy straw (valmuehalm) | N I |
| Prazepam | P IV | 2955-38-6 |
| Proheptazin | N I | 77-14-5 |
| Properidin | N I | 561-76-2 |
| Propiram | N II | 15686-91-6 |
| Propylkatinon (α-propylaminopropiofenon, N-propylkatinon) | Forbudt etter § 5 | 879667-46-6 (HCl-salt) |
| Propylnitazen | Forbudt etter § 5 | 118899-22-2 (HCl-salt) |
| Propylon; se bk-3,4-MDPA | 201474-93-3 |
| Proskalin; se 4-propoksy-3,5-DMPEA | 39201-78-0 |
| Protonitazen | N I | Forbudt etter § 5 | 95958-84-2 |
| Protonitazepyn (N-pyrrolidino protonitazen) | N I | Forbudt etter § 5 | 3038401-95-2 |
| Psilocin (4-HO-DMT) | P I | Forbudt etter § 5 | 520-53-6 |
| Psilocin-O-glukuronid (psilocin glukuronid) | Forbudt etter § 5 | 514212-83-0 |
| Psilocybe cubensis (Cubafleinsopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 |
| Psilocybe semilanceata (Spiss fleinsopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 |
| Psilocybin | P I | Forbudt etter § 5 | 520-52-5 |
| PV9; se a-POP | – |
| Pyrovaleron | P IV | 3563-49-3 |
| Racemetorfan (metorfan) | N I | 510-53-2 |
| Racemoramid (moramid) | N I | 545-59-5 |
| Racemorfan (morfanol) | N I | 297-90-5 |
| RCS-4 | 1345966-78-0 |
| RCS-4 4-hydroksyfenylmetabolitt | 1443988-18-8 |
| RCS-4-C4 homolog | 1345966-77-9 |
| RCS-8 | Forbudt etter § 5 | 1345970-42-4 |
| Remifentanil | N I | 132875-61-7 |
| Rolicyclidin (PCPy) | P I | Forbudt etter § 5 | 2201-39-0 |
| Secbutabarbital (butabarbital) | P IV | 125-40-6 |
| Secobarbital | P II | 76-73-3 |
| Senecioylfentanyl (β-metyl krotonylfentanyl) | Forbudt etter § 5 | – |
| Sopper med innhold av psilocybin eller psilocin (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 |
| Spiss fleinsopp; se Psilocybe semilanceata |
| STP; se DOM | 15588-95-1 |
| Sufentanil | N I | 56030-54-7 |
| Syklobarbital | P III | 52-31-3 |
| Syklopentylfentanyl | Forbudt etter § 5 | 2088918-01-6 |
| Syklopropylfentanyl | N I | Forbudt etter § 5 | 1169-68-2 |
| Tapentadol | 175591-23-8 |
| TCP; se tenocyclidin | 21500-98-1 |
| Tebain (paramorfin) | N I | 115-37-7 |
| Temazepam | P IV | 846-50-4 |
| Tenamfetamin (MDA) | P I | Forbudt etter § 5 | 4764-17-4 |
| Tenocyclidin (TCP) | P I | Forbudt etter § 5 | 21500-98-1 |
| Tetrahydrocannabinol | P II | Forbudt etter § 5 | 1972-08-3 |
| Tetrahydrocannabinol – følgende regioisomere: | P I | Forbudt etter § 5 |
| delta-6a(7)-THC | 59042-44-3 |
| delta-6a(10a)-THC | 7663-50-5 |
| delta-7-THC | 42793-13-5 |
| delta-8-THC | 5957-75-5 |
| delta-9(11)-THC | 27179-28-8 |
| delta-10-THC | 7663-51-6 |
| Tetrahydrofuranylfentanyl | N I | Forbudt etter § 5 | 2142571-01-3 |
| Tetrametylsyklopropanfentanyl (TMCPF) | Forbudt etter § 5 | – |
| Tetrazepam | P IV | 10379-14-3 |
| Thebacon | N I | 466-90-0 |
| TH-PHP | Forbudt etter § 5 | – |
| TH-PVP | Forbudt etter § 5 | 2304915-07-7 |
| Tilidin | N I | 51931-66-9 |
| Tiofentanyl | N I+IV | Forbudt etter § 5 | 1165-22-6 |
| Tiopental | 76-75-5 |
| TMA (3,4,5-trimetoksyamfetamin) | P I | Forbudt etter § 5 | 1082-88-8 |
| TMA-2 (2,4,5-trimetoksyamfetamin) | Forbudt etter § 5 | 1083-09-6 |
| TMA-3 (2,3,4-trimetoksyamfetamin) | Forbudt etter § 5 | 1082-23-1 |
| TMA-6 (2,4,6-trimetoksyamfetamin) | Forbudt etter § 5 | 15402-79-6 |
| Tramadol | 27203-92-5 |
| Trefentanil (A-3665) | Forbudt etter § 5 | 120656-74-8 |
| Triazolam | P IV | 28911-01-5 |
| Trimeperidin (promedol) | N I | 64-39-1 |
| U-47700 | N I | Forbudt etter § 5 | 121348-98-9 |
| UR-144 | P II | Forbudt etter § 5 | 1199943-44-6 |
| Valerylfentanyl | N I | Forbudt etter § 5 | 122882-90-0 |
| Valmuehalm; se poppy straw |
| Vinylbarbital (vinylbital) | P IV | 2430-49-1 |
| XLR-11 | P II | Forbudt etter § 5 | 1364933-54-9 |
| Zipeprol | P II | Forbudt etter § 5 | 34758-83-3 |
| Zolpidem | P IV | 82626-48-0 |
| Zopiklon | 43200-80-2 |
| 2-Brom-meskalin | 2-(2-brom-3,4,5-trimetoksyfenyl)etanamin |
| 2C-B | 2,5-dimetoksy-4-bromfenetylamin |
| 2C-B-FLY | 8-brom-2,3,6,7-tetrahydro-benzo[1,2-b:4,5-b']difuran-4-etanamin |
| 2C-B-NBOMe | 2,5-dimetoksy-4-brom-N-(2-metoksybenzyl)fenetylamin |
| 2C-C | 2,5-dimetoksy-4-klorfenetylamin |
| 2C-C-NBOMe | 2,5-dimetoksy-4-klor-N-(2-metoksybenzyl)fenetylamin |
| 2C-D | 2,5-dimetoksy-4-metylfenetylamin |
| 2C-D-NBOMe | 2,5-dimetoksy-4-metyl-N-(2-metoksybenzyl)fenetylamin |
| 2C-E | 2,5-dimetoksy-4-etylfenetylamin |
| 2-CEC | 2-kloretkatinon |
| 2C-E-NBOMe | 2-(4-etyl-2,5-dimetoksyfenyl)-N-(2-metoksybenzyl)etanamin |
| 2C-F | 2,5-dimetoksy-4-fluorofenetylamin |
| 2C-G | 3,4-dimetyl-2,5-dimetoksyfenetylamin; 2-(2,5-dimetoksy-3,4-dimetylfenyl)etan-1-amin |
| 2C-G-NBOMe | 2,5-dimetoksy-3,4-dimetyl-N-(2-metoksybenzyl)fenetylamin |
| 2C-H | 2,5-dimetoksyfenetylamin |
| 2C-H-NBOMe | 2,5-dimetoksy-N-(2-metoksybenzyl)fenetylamin |
| 2C-I | 2,5-dimetoksy-4-jodfenetylamin |
| 2C-I-NBOMe | 2,5-dimetoksy-4-jod-N-(2-metoksybenzyl)fenetylamin |
| 2C-iP | 2-(2,5-dimetoksy-4-propan-2ylfenyl)etanamin; 2-[2,5-dimetoksy-4-(propan-2-yl)fenyl]etan-1-amin; 2-(4-isopropyl-2,5-dimetoksyfenyl)etan-1-amin; 4-isopropyl-2,5-dimetoksyfenetylamin |
| 2-Cl-4,5-MDMA | 2-klor-4,5-metylendioksymetamfetamin |
| 2-CMC | 2-klormetkatinon |
| 2C-P | 2,5-dimetoksy-4-propylfenetylamin |
| 2C-T-2 | 2,5-dimetoksy-4-etyltiofenetylamin |
| 2C-T-21 | 2-[4-(2-fluoretylsulfanyl)-2,5-dimetoksy-fenyl]etanamin; 2-{4-[(2-fluoretyl)sulfanyl]-2,5-dimetoksyfenyl}etan-1-amin; 4-(2-fluoretyltio)-2,5-dimetoksyfenetylamin |
| 2C-T-4 | 2,5-dimetoksy-4-isopropyltiofenetylamin |
| 2C-T-7 | 2,5-dimetoksy-4-propyltiofenetylamin |
| 2-EEC | 2-etyletkatinon |
| 2-EMC | 2-etylmetkatinon |
| 2-FA | 2-fluoramfetamin |
| 2-FEA | 2-fluoretamfetamin |
| 2-Fluordesklorketamin | 2-(2-fluorfenyl)-2-metylamino-sykloheksanon |
| 2-FMA | 2-fluormetamfetamin |
| 2-FMC | 2-fluormetkatinon |
| 2-Klor-N-etylamfetamin | 1-(2-klorfenyl)-N-etylpropan-2-amin |
| 2-MA | 2-metylamfetamin |
| 2-MEC | 2-metyl-N-etylkatinon |
| 2-Me-PVP | 1-(2-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 1-(2-metylfenyl)-2-pyrrolidin-1-ylpentan-1-on |
| 2-Metyl-AP-237 | 1-[2-metyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on |
| 2-Metyletylbufedron | 2-(etylamino)-1-(2-metylfenyl)butan-1-on; 2-(etylamino)-1-(2-metylfenyl)-1-butanon |
| 2-Metylmetamfetamin | N-metyl-1-(2-metylfenyl)propan-2-amin; metyl[1-(2-metylfenyl)propan-2-yl]amin; n-metyl-1-(o-tolyl)propan-2-amin |
| 2-Metylmetoksyacetylfentanyl | 2-metoksy-N-(2-metylfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| 2-Metyl-α-PiHP | 4-metyl-1-(2-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 4-metyl-2-(pyrrolidin-1-yl)-1-(o-tolyl)pentan-1-on |
| 2-MMA | 2-metoksymetamfetamin |
| 2-MMC | 2-metylmetkatinon |
| 3,4-DCEC | 3,4-dikloretkatinon |
| 3,4-Diklor-N,N-sykloheksylmetylmetkatinon | 2-(sykloheksyl(metyl)amino)-1-(3,4-diklorfenyl)propan-1-on |
| 3,4-Dimetyletkatinon | 1-(3,4-dimetylfenyl)-2-(etylamino)propan-1-on |
| 3,4-Dimetyl-α-PVP | 1-(3,4-dimetylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 3,4-DMA | 3,4-dimetoksyamfetamin |
| 3,4-DMMC | 3,4-dimetylmetkatinon |
| 3,4-EDMC | 3,4-etylendioksymetkatinon; 1-(2,3-dihydro-1,4-benzodioksin-6-yl)-2-(metylamino)-1-propanon |
| 3',4'-MDPBP | 3',4'-metylendioksy-α-pyrrolidinobutyrofenon |
| 3',4'-MDPHP | 3',4'-metylendioksy-α-pyrrolidinoheksiofenon |
| 3,4-Metylendioksy PV8, MDPEP | 1-(1,3-benzodioksol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-on |
| 3,4-Metylendioksy-α-pyrrolidinoisoheksanofenon | 1-(1,3-benzodioksol-5-yl)-4-metyl-2-(1-pyrrolidinyl)-1-pentanon; 1-(1,3-benzodioksol-5-yl)-4-metyl-2-pyrrolidin-1-ylpentan-1-on |
| 3',4'-Tetrametylen-α-pyrrolidinobutiofenon | 2-(1-pyrrolidinyl)-1-(5,6,7,8-tetrahydro-2-naftalenyl)-1-butanon |
| 3-Allylfentanyl | N-[(3S,4R)-1-fenetyl-3-prop-2-enylpiperidin-4-yl]-N-fenylpropanamid |
| 3-BMC | 3-brommetkatinon |
| 3-CEC | 3-kloretkatinon |
| 3-CMC | 3-klormetkatinon |
| 3-EEC | 3-etyletkatinon |
| 3-EMC | 3-etylmetkatinon |
| 3-FA | 3-fluoramfetamin |
| 3-Fluorisobutyrfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-isobutanamid; N-(3-fluorfenyl)-2-metyl-N-[1-(2-fenyletyl)-4-piperidinyl]-propanamid |
| 3-Fluor-α-PPP | 3-fluor-α-pyrrolidinopropiofenon |
| 3-FMA | 3-fluormetamfetamin |
| 3-FMC | 3-fluormetkatinon |
| 3F-NEB | 2-(etylamino)-1-(3-fluorfenyl)butan-1-on |
| 3F-NEH | 2-(etylamino)-1-(3-fluorfenyl)heksan-1-on |
| 3F-PHP | 1-(3-fluorfenyl)-2-pyrrolidin-1-ylheksan-1-on |
| 3F-PiHP | 1-(3-fluorfenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on |
| 3F-α-PVP | 3-fluor-α-pyrrolidinovalerofenon |
| 3-Klorkatinon | 2-amino-1-(3-klorfenyl)propan-1-on; 2-amino-1-(3-klorfenyl)-1-propanon |
| 3-Klor-N-etylamfetamin | 1-(3-klorfenyl)-N-etylpropan-2-amin |
| 3-MAM | 3-acetylmorfin |
| 3-MeA | 3-metylamfetamin |
| 3-MEC | 3-metyl-N-etylkatinon |
| 3-MeOMC | 3-metoksymetkatinon |
| 3-MeO-NBOMe | 2-(3-metoksyfenyl)-N-[(2-metoksyfenyl)metyl]etan-1-amin |
| 3'-Me-PVP | 1-(3-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 3-Metoksyamfetamin | 1-(3-metoksyfenyl)propan-2-amin |
| 3-Metylbutyrfentanyl | N-[3-metyl-1-(2-fenyletyl)piperidin-4-yl]-N-fenylbutanamid |
| 3-Metylflefedron | 3-metyl-4-fluormetkatinon |
| 3-Metyl-N-propyl-katinon | 2-(propylamino)-1-(3-metylfenyl)-1-propanon; 2-(propylamino)-1-(m-tolyl)propan-1-on |
| 3-Metyl-α-PHiP | 4-metyl-1-(3-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 4-metyl-2-(pyrrolidin-1-yl)-1-(m-tolyl)pentan-1-on |
| 3-MMC | 3-metylmetkatinon |
| 4,4'-DMAR | para-metyl-4-metylaminorex (4,4'-dimetylaminorex) |
| 4-AcO-DET | 4-acetoksy-N,N-dietyltryptamin |
| 4-AcO-DiPT | 4-acetoksy-N,N-diisopropyltryptamin |
| 4-AcO-DMT | 4-acetoksy-N,N-dimetyltryptamin |
| 4-AcO-EPT | [3-[2-[etyl(propyl)amino]etyl]-1H-indol-4-yl] acetat; 3-[2-(etylpropylamino)etyl]-1H-indol-4-ol, 4-acetat |
| 4-AcO-MET | 4-acetoksy-N-metyl-N-etyltryptamin |
| 4-AcO-MiPT | 4-acetoksy-N-metyl-N-isopropyltryptamin |
| 4-AcO-MPT | 3-[2-(metylpropylamino)etyl]-1H-indol-4-ol, 4-acetat |
| 4-BMC | 4-brommetkatinon |
| 4-Bromfentanyl | N-(4-bromfenyl)-N-[1-(2-fenyletyl)piperidin-4-yl]propanamid |
| 4Br-α-PPP | 4-brom-α-pyrrolidinopropiofenon |
| 4Br-α-PVP | 4-brom-α-pyrrolidinovalerofenon |
| 4-CA | 4-kloramfetamin |
| 4-CBC | 4-klor-N-butylkatinon |
| 4C-D | 1-(2,5-dimetoksy-4-metylfenyl)butan-2-amin |
| 4-CEC | 4-kloretkatinon |
| 4-CIC | 4-klorisopropylkatinon |
| 4-Cl-3-MMC | 1-(4-klor-3-metylfenyl)-2-(metylamino)propan-1-on |
| 4-CMA | 4-klormetamfetamin |
| 4-CMC | 4-klormetkatinon |
| 4-EEC | 4-etyletkatinon |
| 4-Etyl-α-PVP | 4-etyl-α-pyrrolidinopentiofenon |
| 4F-3-metyl-α-PHP | 1-(4-fluor-3-metylfenyl)-2-pyrrolidin-1-yl-heksan-1-on; 1-(4-fluor-3-metylfenyl)-2-(pyrrolidin-1-yl)heksan-1-on |
| 4-FEC | 4-fluoretkatinon |
| 4-Fenylfentanyl | N-fenyl-N-[4-fenyl-1-(2-fenyletyl)piperidin-4-yl]propanamid |
| 4-FIBF | 4-fluorisobutyrfentanyl |
| 4-Fluor-N-isopropylpentedron | 1-(4-fluorfenyl)-2-(1-metyletylamino)pentan-1-on |
| 4-Fluorpentedron | 4-fluor-α-metylaminovalerofenon |
| 4-FMA | 4-fluormetamfetamin |
| 4-FMC | 4-fluormetkatinon |
| 4F-MDMB-BINACA | metyl 2-(1-(4-fluorbutyl)-1H-indazol-3-karboksamido)-3,3-dimetylbutanoat |
| 4F-NEB | 4-fluor-N-etylbufedron, 2-(etylamino)-1-(4-fluorfenyl)butan-1-on |
| 4F-NEP | 4-fluor-N-etylpentedron |
| 4F-PBP | 4-fluor-α-pyrrolidinobutyrofenon |
| 4F-α-PHiP | 1-(4-fluorfenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on |
| 4F-α-PHP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)heksan-1-on, 4-fluor-α-pyrrolidinoheksanofenon |
| 4F-α-POP | 4-fluor-α-pyrrolidinooktafenon |
| 4F-α-PVP | 4-fluor-α-pyrrolidinovalerofenon |
| 4F-α-PVP piperidinanalog | 1-(4-fluorfenyl)-2-(piperidin-1-yl)pentan-1-on |
| 4-HO-DET | 4-hydroksy-N,N-dietyltryptamin |
| 4-HO-DPT | 3-[2-(dipropylamino)etyl]-1H-indol-4-ol |
| 4-HO-EPT | 3-{2-[etyl(propyl)amino]etyl}-1H-indol-4-ol |
| 4-HO-McPT | 3-{2-[syklopropyl(metyl)amino]etyl}-1H-indol-4-ol |
| 4-HO-MET | 4-hydroksy-N-metyl-N-etyltryptamin |
| 4-HO-MiPT | 4-hydroksy-N-metyl-N-isopropyltryptamin |
| 4-HO-MPT | 3-{2-[metyl(propyl)amino]etyl}-1H-indol-4-ol |
| 4-Hydroksy DiPT | 4-hydroksy-N,N-diisopropyltryptamin; 3-[2-(diisopropylamino)etyl]-1H-indol-4-ol |
| 4'-Hydroksynitazen | 4-[[1-[2-(dietylamino)etyl]-5-nitro-1H-benzimidazol-2-yl]metyl]-fenol |
| 4-Klor-N,N-DMC | 1-(4-klorfenyl)-2-(dimetylamino)-1-propanon |
| 4-Klor-N-etylamfetamin | 1-(4-klorfenyl)-N-etyl-2-propanamin; 1-(4-klorfenyl)-N-etylpropan-2-amin; 4-klor-N-etyl-α-metyl-benzenetanamin |
| 4-Klorpentedron | 4-klor-α-metylaminovalerofenon |
| 4-Klor-α-PHP | 1-(4-klorfenyl)-2-pyrrolidin-1-ylheksan-1-on |
| 4-Klor-α-PPP | 4-klor-α-pyrrolidinopropiofenon |
| 4-Klor-α-PVP | 4-klor-α-pyrrolidinovalerofenon |
| 4-MA | 4-metylamfetamin |
| 4-MBC | 4-metyl-N-benzylkatinon |
| 4-MC | 4-metylkatinon |
| 4-MEC | 4-metyl-N-etylkatinon |
| 4-MEC (4-metyletkatinon) | 2-(etylamino)-1-(4-metylfenyl)propan-1-on |
| 4-MeMABP | 4-metyl-a-metylaminobutyrofenon |
| 4-MeO-MiPT | N-[2-(4-metoksy-1H-indol-3-yl)etyl]-N-metylpropan-2-amin |
| 4-MeOPBP | 4'-metoksy-alfa-pyrrolidinobutiofenon |
| 4-MeO-α-PVP | 4-metoksy-α-pyrrolidinovalerofenon |
| 4-Metoksy PV8 | 1-(4-metoksyfenyl)-2-pyrrolidin-1-ylheptan-1-on |
| 4-Metoksy PV9 | 1-(4-metoksyfenyl)-2-pyrrolidin-1-yloktan-1-on |
| 4'-Metylheksedron | 2-(metylamino)-1-(4-metylfenyl)-1-heksanon; 2-(metylamino)-1-(4-metylfenyl)heksan-1-on |
| 4'-Metyl-N-isopropylpentedron | 2-((1-metyletyl)amino)-1-(4-metylfenyl)-1-pentanon; 1-(4-metylfenyl)-2-(propan-2-ylamino)pentan-1-on |
| 4'-Metyl-α-PiHP | 4-metyl-2-pyrrolidin-1-yl-1-(4-metylfenyl)pentan-1-on; 4-metyl-1-(4-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 4'-Metyl-α-pyrrolidinobutiofenon | (RS)-1-(4-metylfenyl)-2-(1-pyrrolidinyl)-1-butanon |
| 4-MMA | 4-metylmetamfetamin |
| 4-MPD | 4-metylpentedron |
| 4-MTA | 4-metyltioamfetamin |
| 4-Propoksy-3,5-DMPEA | 4-propoksy-3,5-dimetoksyfenetylamin |
| 5-AcO-DET | 5-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-5-yl acetat |
| 5-DBFPV | 5-dihydrobenzofuranpyrovaleron |
| 5F-AMB-PINACA | metyl (1-(5-fluorpentyl)-1H-indazole-3-karbonyl)valinat |
| 5F-APINACA (5F-AKB-48) | N-(adamantan-1-yl)-1-((5-fluorpentyl)-1H-indazol-3-karboksamid |
| 5F-JWH-398 | (4-klornaftalen-1-yl)-[1-(5-fluorpentyl)indol-3-yl]metanon |
| 5F-MDMB-PICA | metyl 2-(1-(5-fluorpentyl)-1H-indole-3-karboksamido)-3,3-dimetylbutanoat |
| 5F-MDMB-PINACA | metyl-2-{[1-(5-fluorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimetylbutanoat |
| 5F-PB-22 | quinolin-8-yl 1-(5-fluorpentyl)-1H-indol-3-karboksylat |
| 5-IT | 5-(2-aminopropyl)indol |
| 5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-metylpropan-2-amin |
| 5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-metylpropan-2-amin |
| 5-MeO-DBT | N-butyl-N-[2-(5-metoksy-1H-indol-3-yl)etyl]butan-1-amin |
| 5-MeO-DiPT | 5-metoksy-N,N-diisopropyltryptamin |
| 5-MeO-DMT | 5-metoksy-N,N-dimetyltryptamin |
| 5-MeO-EiPT | 5-metoksy-N-etyl-N-isopropyltryptamin |
| 5-MeO-MET | 5-metoksy-N-metyl-N-etyltryptamin |
| 5-MeO-MiPT | 5-metoksy-N-metyl-N-isopropyltryptamin |
| 6-AcO-DET | 6-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-6-yl acetat |
| 6-MAM | 6-acetylmorfin |
| 6-Metoksy-MDA | 6-metoksy-3,4-metylendioksyamfetamin |
| 6-Nikotinoylmorfin | (4R,4aR,7S,7aR,12bS)-9-hydroksy-3-metyl-2,3,4,4a,7,7a-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl nikotinat; [(4R,4aR,7S,7aR,12bS)-9-hydroksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl] pyridin-3-karboksylat |
| 7-AcO-DET | 7-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-7-yl acetat |
| 7-hydroksymitragynin (7-HMG) | 7α-hydroksy-7H-mitragynin |
| α-EPP | α-etylaminopentiofenon |
| α-Metyl butyryl fentanyl | 2-metyl-N-fenyl-N-[1-(2-fenyletyl)-4-piperidinyl]-butanamid |
| α-PBP | α-pyrrolidinobutiofenon |
| α-PEP | α-pyrrolidinoenantofenon |
| α-PHP | α-pyrrolidinoheksanofenon |
| α-PHPP | α-pyrrolidinoheptofenon |
| α-PiHP | 4-metyl-1-fenyl-2-(pyrrolidin-1-yl)pentan-1-on |
| α-PNP | 1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on |
| α-POP | a-pyrrolidinooktafenon |
| α-PPP | α-pyrrolidinopropiofenon |
| α-PVP | α-pyrrolidinovalerofenon |
| α-TMT | α-N,N-trimetyltryptamin |
| AB-CHMINACA | N-[1-amino-3-metyl-1-oksobutan-2-yl]-1-(sykloheksylmetyl)-1H-indazol-3-karboksamid |
| AB-FUBINACA | (S)-N-(1-amino-3-metyl-1-oksobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboksamid |
| AB-PINACA | N-[1-amino-3-metyl-1-oksobutan-2-yl]-1-pentyl-1H-indazol-3-karboksamid |
| ADB-BUTINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-butyl-1H-indazol-3-karboksamid |
| ADB-CHMINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-(sykloheksylmetyl)-1H-indazol-3-karboksamid |
| ADB-FUBINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboksamid |
| AH-7921 | 3,4-diklor-N-((1-(dimetylamino)sykloheksyl)metyl)benzamid |
| Allyleskalin | 3,5-dimetoksy-4-(allyloksy)fenetylamin |
| AM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 2-hydroksyindol metabolitt | (1-(5-fluorpentyl)-2-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 5-hydroksyindol metabolitt | (1-(5-fluorpentyl)-5-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 6-hydroksyindol metabolitt | (1-(5-fluorpentyl)-6-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 7-hydroksyindol metabolitt | [1-(5-fluorpentyl)-7-hydroksy-1H-indol-3-yl](1-naftyl)metanon; [1-(5-fluorpentyl)-7-hydroksyindol-3-yl]-naftalen-1-ylmetanon; [1-(5-fluorpentyl)-7-hydroksyindol-3-yl]-naftalen-1-ylmetanon |
| AM-2201 kloranalog | (1-(5-klorpentyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-679 | (1-pentyl-1H-indol-3-yl)(2-jodfenyl)metanon |
| AM-694 | (1-(5-fluorpentyl)-1H-indol-3-yl)(2-jodfenyl)metanon |
| Amineptin | 7-((10,11-dihydro-5H-dibenzo[a,d]-syklohepten-5-yl)amino)heptansyre |
| β-metylfentanyl | N-fenyl-N-[1-(2-fenylpropyl)piperidin-4-yl]propanamid |
| BDB | 1,3-benzodioksolylbutanamin |
| bk-3,4-MDPA | β-keto-3,4-metylenedioksypropylamfetamin |
| bk-6-metoksy-MDMA | β-keto-6-metoksy-3,4-metylendioksymetamfetamin |
| bk-DMBDB | β-keto-dimetylbenzodioksolylbutanamin |
| bk-EBDB | β-keto-N-etyl-1,3-benzodioksolylbutanamin |
| bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(metylamino)propan-1-on |
| bk-IVP | 1-(2,3-dihydro-1-inden-5-yl)-2-(etylamino)pentan-1-on |
| bk-MBDB | β-keto-metylbenzodioksolylbutanamin |
| bk-MDDMA | β-keto-3,4-metylendioksydimetylamfetamin |
| bk-MDEA | β-keto-metylendioksy-N-etylamfetamin |
| bk-MDMA | β-keto-3,4-metylendioksymetamfetamin |
| bk-MMDMA | β-keto-5-metoksy-3,4-metylendioksymetamfetamin |
| bk-PBDB | β-keto-N-propylbenzodioksolylbutanamin |
| bk-PMMA | β-keto-para-metoksymetamfetamin |
| BMDB | 2-benzylamino-1-(3,4-metylendioksyfenyl)butan-1-on |
| BMDP | 3,4-metylendioksy-N-benzylkatinon |
| Brifentanil | N-[(3R,4S)-1-[2-(4-etyl-5-oksotetrazol-1-yl)etyl] -3-metylpiperidin-4-yl]-N-(2-fluorfenyl)-2-metoksyacetamid; N-[1-[2-(4-etyl-5-oksotetrazol-1-yl)etyl]-3-metylpiperidin-4-yl]-N-(2-fluorfenyl)-2-metoksyacetamid |
| Bromazolam | 8-brom-6-fenyl-1-metyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin |
| Brorfin | 1-[1-[1-(4-bromofenyl)etyl]-piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-on |
| Butonitazen | 2-[(4-butoksyfenyl)metyl]-5-nitro-1-(2-pyrrolidin-1-yletyl)benzimidazol |
| Codeine Impurity D (EP) | (4R,4aR,7S,7aR,12bS)-10-[[(4R,4aR,7S,7aR,12bS)-7-hydroksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-9-yl]oksy]-9-metoksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-ol; 4,5α-epoksy-2-[(4,5α-epoksy-6α-hydroksy-17-metyl-7,8-didehydromorfinan-3-yl)oksy]-3-metoksy-17-metyl-7,8-didehydromorfinan-6α-ol |
| CP 47,497 | cannabisykloheksanol |
| CP 55,940 | 2-(5-hydroksy-2-(3-hydroksypropyl)-sykloheksyl)-5-(2-metyloktan-2-yl)fenol |
| CP-47,497-C8-homolog | 2-(3-hydroksysykloheksyl)-5-(2-metylnonan-2-yl)fenol |
| CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(1-metyl-1-fenyl-etyl)indazol-3-karboksamid |
| CUMYL-PEGACLONE | 2-(1-metyl-1-fenyl-etyl)-5-pentyl-pyrido[4,3-b]indol-1-on |
| delta-6a(7)-THC | (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta-6a(10a)-THC | 7,8,9,10-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| delta-7-THC | (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta-8-THC | (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta8-THC acetat | 6aR,7,10,10aR-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, 1-acetat |
| delta-9-THC | (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9- trimetyl-3-pentyl-6H-dibenzo[b,d]pyran1-ol |
| delta9-THC acetat | 6aR,7,8,10aR-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, 1-acetat; (6aR,10aR)-6,6,9-trimetyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl acetat |
| delta-9(11)-THC | (6aR,10aR)-6a,7,8,9,10,10a-heksahydro-6,6-dimetyl-9-metylen-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| delta-10-THC | 6a,7,8,9-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| DET | N,N-dietyltryptamin |
| DiPT | N,N-diisopropyltryptamin |
| DL-4662 | 1-(3,4-dimetoksyfenyl)-2-(etylamino)pentan-1-on |
| DMA | 2,5-dimetoksyamfetamin |
| DMHP | dimetylheptylpyran |
| DMT | N,N-dimetyltryptamin |
| DOB | 2,5-dimetoksy-4-bromamfetamin |
| DOC | 2,5-dimetoksy-4-kloramfetamin |
| DOET | 2,5-dimetoksy-4-etylamfetamin |
| DOI | 2,5-dimetoksy-4-jodamfetamin |
| DOM/STP | 2,5-dimetoksy-4-metylamfetamin |
| DOPR | 2,5-dimetoksy-4-propylamfetamin |
| DOT | 2,5-dimetoksy-4-metyltioamfetamin |
| DPT | N,N-dipropyltryptamin |
| EAM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(4-etyl-1-naftalenyl)-metanon |
| Eskalin | 3,5-dimetoksy-4-etoksyfenetylamin |
| Etometazen | 2-[2-(4-etoksybenzyl)-5-metyl-1H-benzo[d]imidazol-1-yl]-N,N-dietyletanamin; 2-[(4-etoksyfenyl)metyl]-N,N-dietyl-5-metyl-1H-benzimidazol-1-etanamin |
| Etonitazepipne | 2-[(4-etoksyfenyl)metyl]-5-nitro-1-(2-piperidin-1-yletyl)benzimidazol |
| Etyl morfin 6-β-D-glukuronid | (2S,3S,4S,5R,6R)-6-(((4R,4aR,7S,7aR,12bS)-9-etoksy-3-metyl-2,3,4,4a,7,7a-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl)oksy)-3,4,5-trihydroksytetrahydro-2H-pyran-2-karboksylsyre |
| Etylpropyltryptamin | N-etyl-N-propyl-1H-indol-3-etanamin; N-etyl-N-[2-(1H-indol-3-yl)etyl]propan-1-amin |
| Fenaridin | N-[2,5-dimetyl-1-(2-fenyletyl)piperidin-4-yl]-N-fenylpropanamid; N-[2,5-dimetyl-1-(2-fenyletyl)-4-piperidinyl]-N-fenylpropanamid |
| Fenibut (Phenibut) | 4-amino-3-fenylbutansyre |
| Flunitazen | N,N-dietyl-2-[2-[(4-fluorfenyl)metyl]-5-nitrobenzimidazol-1-yl]etanamin |
| FUB-AMB | metyl (1-(4-fluorbenzyl)-1H-indazol-3-karbonyl)valinat |
| GHB | γ-hydroksybutyrat |
| Hexahydrocannabinol | (6aR,10aR)-6,6,9-trimetyl-3-pentyl-6a,7,8,9,10,10a-heksahydrobenzo[c]chromen-1-ol |
| Iso-butonitazen | N,N-dietyl-2-(2-(4-isobutoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)etan-1-amin |
| Isobutyrylfentanyl | 2-metyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid |
| Isoheksedron | 4-metyl-2-(metylamino)-1-fenylpentan-1-on |
| Isoheksylon | 4,N-dimetylpentylon; 1-(1,3-benzodioksol-5-yl)-(etylamino)heksan-1-on; 1-(benzo[d][1,3]dioksol-5-yl)-4-metyl-2-(metylamino)pentan-1-on |
| JWH-007 | (2-metyl-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-011 | (1-(heptan-2-yl)-2-metyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-015 | (2-metyl-1-propyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-016 | (1-butyl-2-metyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-018 | naftalen-1-yl(1-pentyl-1H-indol-3-yl)metanon |
| JWH-018 2-hydroksyindol metabolitt | (2-hydroksy-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon; (2-hydroksy-1-pentylindol-3-yl)-naftalen-1-ylmetanon |
| JWH-019 | (1-heksyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-020 | (1-heptyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-022 | naftalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3-yl)metanon |
| JWH-030 | naftalen-1-yl(1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-031 | (1-heksyl-1H-pyrrol-3-yl)(naftalen-1-yl)metanon |
| JWH-047 | (1-butyl-2-metyl-1H-indol-3-yl)(7-metylnaftalen-1-yl)metanon |
| JWH-048 | (2-metyl-1-pentyl-1H-indol-3-yl)(7-metylnaftalen-1-yl)metanon |
| JWH-071 | (1-etyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-072 | naftalen-1-yl(1-propyl-1H-indol-3-yl)metanon |
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-081 | (4-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-098 | (4-metoksynaftalen-1-yl)(2-metyl-1-pentyl-1H-indol-3-yl)metanon |
| JWH-116 | (2-etyl-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-120 | (4-metylnaftalen-1-yl)(1-propyl-1H-indol-3-yl)metanon |
| JWH-122 | (4-metylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-122N-(4-pentenyl) analog | (4-metylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)metanon |
| JWH-145 | naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)metanon |
| JWH-147 | (1-heksyl-5-fenyl-1H-pyrrol-3-yl)(naftalen-1-yl)metanon |
| JWH-148 | (2-metyl-1-propyl-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| JWH-149 | (2-metyl-1-pentyl-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| JWH-164 | (7-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-166 | (6-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-167 | 1-(1-pentyl-1H-indol-3-yl)-2-fenyletan-1-on |
| JWH-171 | (Z)-1-((3-pentyl-1H-inden-1-yliden)metyl)naftalen |
| JWH-175 | 3-(naftalen-1-ylmetyl)-1-pentyl-1H-indol |
| JWH-176 | (E)-1-((3-pentyl-1H-inden-1-yliden)metyl)naftalen |
| JWH-180 | (1-propyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-181 | (2-metyl-1-pentyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-182 | (1-pentyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-184 | 3-((4-metylnaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-185 | 3-((4-metoksynaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-192 | 4-(2-(3-((4-metylnaftalen-1-yl)metyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-193 | (4-metylnaftalen-1-yl)(1-(2-morfolinoetyl)-1H-indol-3-yl)metanon |
| JWH-194 | 2-metyl-3-((4-metylnaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-195 | 4-(2-(3-(naftalen-1-ylmetyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-196 | 2-metyl-3-(naftalen-1-ylmetyl)-1-pentyl-1H-indol |
| JWH-197 | 3-((4-metoksynaftalen-1-yl)metyl)-2-metyl-1-pentyl-1H-indol |
| JWH-198 | (4-metoksynaftalen-1-yl)(1-(2-morfolinoetyl)-1H-indol-3-yl)metanon |
| JWH-199 | 4-(2-(3-((4-metoksynaftalen-1-yl)metyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-200 | (1-(2-morfolinoetyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-201 | 2-(4-metoksyfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-203 | 2-(2-klorfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-205 | 1-(2-metyl-1-pentyl-1H-indol-3-yl)-2-fenyletan-1-on |
| JWH-210 | (4-etylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-250 | 2-(2-metoksyfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-251 | 1-(1-pentyl-1H-indol-3-yl)-2-(o-tolyl)etan-1-on |
| JWH-302 | 1-pentyl-3-(3-metoksyfenylacetyl)indol; 2-(3-metoksyfenyl)-1-(1-pentylindol-3-yl)etanon |
| JWH-307 | (5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmetanon |
| JWH-308 | naftalen-1-yl(5-(4-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-309 | 1-naftalenyl[5-(1-naftalenyl)-1-pentyl-1H-pyrrol-3-yl]-metanon |
| JWH-368 | naftalen-1-yl(5-(3-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-369 | [5-(2-klorfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-metanon |
| JWH-398 | (4-klornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| Karisoprodol | N-isopropyl-2-metyl-2-propyl-1,3-propandiol dikarbamat; (RS)-2-{[(aminokarbonyl)oksy]metyl}-2-metylpentyl isopropylkarbamat |
| Ketamin | 2-(2-klorfenyl)-2-(metylamino)sykloheksan-1-on |
| Lofentanil | metyl (3S,4R)-3-metyl-1-(2-fenyletyl)-4-[fenyl(propionyl)amino]piperidin-4-karboksylat |
| MABP | α-metylaminobutyrofenon |
| MAL | 3,5-dimetoksy-4-(metylallyloksy)fenetylamin |
| MAM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| MAM-2201 kloranalog | (1-(5-klorpentyl)-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| MBDB | metylbenzodioksolylbutanamin |
| MDA | 3,4-metylendioksyamfetamin |
| MDMA | 3,4-metylendioksymetamfetamin |
| MDMB-4en-PINACA | metyl 3,3-dimetyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboksamido)butanoat |
| MDMB-CHMICA | metyl N-{[1-(sykloheksylmetyl)-1H-indol-3-yl]karbonyl}-3-metyl-L-valinat |
| MDPPP | 3,4-metylendioksy-α-pyrrolidinopropiofenon |
| MDPT(tBuONE) | 3,4-metylendioksy-N-tert-butylkatinon |
| MDPV | 3,4-metylendioksypyrovaleron |
| Menitazen | N,N-dietyl-2-[(4-metylfenyl)metyl]-5-nitro-1H-benzimidazol-1-etanamin; N,N-dietyl-2-[2-[(4-metylfenyl)metyl]-5-nitrobenzimidazol-1-yl]etanamin |
| MET | N-metyl-N-etyltryptamin |
| Metafedrin | N-metyl-1-(3-metylfenyl)propan-2-amin |
| Metamfepramon | 2-(dimetylamino)-1-fenyl-1-propanon; (RS)-2-dimetylamino-1-fenylpropan-1-on |
| Metodesnitazen | N,N-dietyl-2-[2-[(4-metoksyfenyl)metyl]benzimidazol-1-yl]etanamin |
| Metonitazen | N,N-dietyl-2-(2-(4-metoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)etan-1-amin |
| Metylendioksykatinon | (±)-2-amino-1-(3,4-metylendioksyfenyl)propan-1-on |
| MFPVP | 1-(3-metyl-4-fluorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| Mitragynin | metyl (16E)-9,17-dimetoksy-16,17-didehydro-2 0β-corynan-16-karboksylat |
| MMDA | 5-metoksy-3,4-metylendioksyamfetamin |
| MOPPP | 4'-metoksy-alfa-pyrrolidinoproiofenon |
| MPA (metiopropamin) | N-metyl-1-(tiofen-2-yl)propan-2-amin |
| MPHP | 4-metylfenylpyrrolidinylheksanon |
| MPPP | 4'-metyl-alfa-pyrrolidinopropiofenon |
| MPPP | 1-metyl-4-fenylpiperidin-4-yl propionat |
| MT-45 | 1-sykloheksyl-4-(1,2-difenyletyl)piperazin |
| N,N-dietylheksedron | 2-(dietylamino)-1-fenylheksan-1-on; 2-(dietylamino)-1-fenyl-heksan-1-on |
| N,N-dietylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(dietylamino)pentan-1-on; 1-(1,3-benzodioksol-5-yl)-2-(dietylamino)-1-pentanon |
| N-butyl bufedron | 2-(butylamino)-1-fenylbutan-1-on |
| N-butylbutylon | 1-(2H-1,3-benzodioksol-5-yl)-2-(butylamino)butan-1-on; 1-(benzo[d][1,3]dioksol-5-yl)-2-(butylamino)butan-1-on |
| N-Butylheksedron | 2-(butylamino)-1-fenyl-1-heksanon |
| N-butyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(butyl(metyl)amino)butan-1-on |
| N-butylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(butylamino)pentan-1-on; 1-(2H-1,3-benzodioksol-5-yl)-2-(butylamino)pentan-1-on |
| N-desetyl etonitazen | 2-[(4-etoksyfenyl)metyl]-N-etyl-5-nitro-1H-benzimidazol-1-etanamin; 2-[2-(4-etoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]-N-etyletanamin; 2-[2-[(4-etoksyfenyl)metyl]-5-nitrobenzimidazol-1-yl]-N-etyletanamin |
| N-desetylisotonitazen | N-etyl-2-[[4-(1-metyletoksy)fenyl]metyl]-5-nitro-1H-benzimidazol-1-etanamin; N-etyl-2-[5-nitro-2-[(4-propoksyfenyl)metyl]benzimidazol-1-yl]etanamin |
| NEB | N-etylbufedron |
| N-etyl 2C-B | 2-(4-brom-2,5-dimetoksyfenyl)-N-etyletanamin |
| N-etylheksedron | 2-(etylamino)-1-fenylheksan-1-on |
| N-Etylheksylon | 1-(1,3-benzodioksol-5-yl)-(etylamino)heksan-1-on |
| N-etylheptylon | 3,4-metylendioksy-α-etylheptanofenon; 1-(1,3-benzodioksol-5-yl)-2-(etylamino)heptan-1-on |
| N-etylisoheksedron | 2-(etylamino)-4-metyl-1-fenyl-pentan-1-on |
| N-etyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(etyl(metyl)amino)butan-1-on |
| N-etylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(etylamino)-1-pentanon |
| N-isobutylheksedron | 2-[(2-metylpropyl)amino]-1-fenylheksan-1-on; 2-(isobutylamino)-1-fenylheksan-1-on |
| N-Me-2C-B | N-metyl-2,5-dimetoksy-4-bromfenetylamin |
| N-Me-2C-H | 2,5-dimetoksy-N-metylfenetylamin |
| N-metyletylon | 1-(1,3-benzodioksol-5-yl)-2-(etylmetylamino)-1-propanon; 1-(1,3-benzodioksol-5-yl)-2-[etyl(metyl)amino]propan-1-on |
| N-metyl-N-propyl metylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(metyl(propyl)amino)propan-1-on |
| NMT | N-metyltryptamin |
| Norkodein-6-glukuronid | (2S,3S,4S,5R,6R)-6-[[(4R,4aR,7S,7aR,12bS)-9-metoksy-1,2,3,4,4a,7,7a,13-oktahydro-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl]oksy]-3,4,5-trihydroksyoksan-2-karboksylsyre |
| N-pentylmetylon | 1-(benzo[d][1,3]dioksol-5-yl)2-pentylamino)propan-1-on; 1-(1,3-benzodioksol-5-yl)-2-(pentylamino)propan-1-on |
| N-propyl bufedron | 1-fenyl-2-(propylamino)-1-butanon |
| N-propyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(metyl(propyl)amino)propan-1-on |
| N-propylnorpentedron | 1-fenyl-2-(propylamino)pentan-1-on |
| N-pyrrolidino metonitazen | 2-(4-metoksybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)etyl-1H-benzo[d]imidazol |
| N-sec-butyl pentedron | 2-[(butan-2-yl)amino]-1-fenylpentan-1-on; 2-[(1-metylpropyl)amino]-1-fenyl-1-pentanon |
| Oksymorfon-3-β-D-glukuronid | (2S,3S,4S,5R,6S)-3,4,5-trihydroksy-6-(((4R,4aS,7aR,12bS)-4a-hydroksy-3-metyl-7-okso-2,3,4,4a,5,6,7,7a-oktahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-9-yl)oksy)tetrahydro-2H-pyran-2-karboksylsyre |
| Orto-fluorfuranylfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-2-furankarboksamid |
| Para-bromamfetamin | 1-(4-bromfenyl)propan-2-amin |
| Para-fluorfuranylfentanyl | N-(4-fluorfenyl)-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboksamid |
| Para-klor metoksyacetyl fentanyl | N-(4-klorfenyl)-2-metoksy-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| Para-klorfentanyl | N-(4-klorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-propanamid |
| Para-metoksy metoksyacetyl fentanyl | 2-metoksy-N-(4-metoksyfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| Para-metylsyklopropylfentanyl | N-(4-metylfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-syklopropankarboksamid |
| PCE | N-etyl-1-fenylsykloheksanamin |
| PCPy | 1-(1-fenylsykloheksyl)pyrrolidin |
| Pentedron | α-metylaminovalerofenon |
| Pentylon | 1-(1,3-benzodioksol-5-yl)-2-(metylamino)-2-pentanon |
| PEPAP | 1-fenetyl-4-fenylpiperidin-4-yl acetat |
| PMA | para-metoksyamfetamin |
| Propylkatinon | 1-fenyl-2-(propylamino)-1-propanon; 1-fenyl-2-(propylamino)propan-1-on |
| Propylnitazen | N,N-dietyl-2-(5-nitro-2-(4-propylbenzyl)-1H-benzo[d]imidazol-1-yl)etan-1-amin; N,N-dietyl-2-[5-nitro-2-[(4-propylfenyl)metyl]benzimidazol-1-yl]etanamin |
| Protonitazepyn | 5-nitro-2-(4-propoksybenzyl)-1-(2-(pyrrolidin-1-yl)etyl)-1H-benzo[d]imidazol |
| Psilocin-O-glukuronid | (2S,3S,4S,5R,6S)-6-((3-(2-(dimetylamino)etyl)-1H-indol-4-yl)oksy)-3,4,5-trihydroksytetrahydro-2H-pyran-2-karboksylsyre |
| RCS-4 | (4-metoksyfenyl)(1-pentyl-1H-indol-3-yl)metanon |
| RCS-4 4-hydroksyfenylanalog | (4-hydroksyfenyl)(1-pentyl-1H-indol-3-yl)metanon |
| RCS-4-C4 | (1-butyl-1H-indol-3-yl)(4-metoksyfenyl)metanon |
| RCS-8 | 2-(2-metoksyfenyl)-1-[1-(2-sykloheksyletyl)indol-3-yl]etanon |
| TCP | 1-(1-(2-tienyl)sykloheksyl)piperidin |
| TH-PHP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)heksan-1-on |
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on |
| TMA | 3,4,5-trimetoksyamfetamin |
| TMA-2 | 2,4,5-trimetoksyamfetamin |
| TMA-3 | 1-(2,3,4-trimetoksyfenyl)propan-2-amin |
| TMA-6 | 2,4,6-trimetoksyamfetamin |
| Trefentanil | N-{1-[2-(4-etyl-5-okso-4,5-dihydro-1H-tetrazol-1-yl)etyl]-4-fenylpiperidin-4-yl}-N-(2-fluorfenyl)propanamid |
| U-47700 | 3,4-dikloro-N-(2-dimetylamino-sykloheksyl)-N-metyl-benzamid |
| UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylsyklopropyl)metanon |
| XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetrametylsyklopropyl)metanon |
| Zopiklon | [6-(5-klor-2-pyridinyl)-5-okso-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-metylpiperazin-1-karboksylat |









